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     Bacteria utilize small signaling molecules, or autoinducers, to regulate their gene 
expression in tandem by a process termed quorum sensing.  The gene encoding the 
synthase for autoinducer-2 (AI-2), luxS, is conserved in dozens of diverse bacteria.  
Behaviors controlled by AI-2 include virulence, motility, toxin production, and biofilm 
formation.  The development of therapies that interfer  with AI-2 quorum sensing are 
attractive for targeting biofilms, which exhibit inherent resistance to most antibiotics and 
biocidal agents.  In this study, in vitro synthesized AI-2, LuxS inhibitors, and (5Z)-4-
bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone were screened for their effect on 
biofilm formation in Escherichia coli, Bacillus cereus, and Listeria innocua.  The LuxS 
inhibitors were found to have no influence on biofilm formation in any of the screened 
species, but reduced exponential phase AI-2 production in Listeria innocua.  The 
brominated furanone significantly inhibited growth in B. cereus and L. innocua, and 
under certain conditions preferentially inhibited biofilm formation independently from 
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Chapter 1:  Introduction 
 
     Bacterial biofilms are multicellular aggregations that occur at interfaces.  The 
prevalence of biofilms and their negative role in chronic infectious diseases has been 
gaining significant attention in recent years.  Biofilms readily develop on implanted 
medical devices, leading to ubiquitous infections from such common procedures as 
catheterization.  Many industrial problems, such as the fouling of process equipment and 
corrosion, are caused or exacerbated by bacterial biofilms.  Complicating the control of 
bacterial biofilms is their extraordinary resistance to most antibiotics and biocidal 
treatments.  Quorum sensing inhibitors are a novel class of drugs that have great potential 
for selective activity against multicellular bacterial behaviors such as virulence and 
biofilm formation.  Bacteria have been found to excr te and detect small signaling 
molecules (autoinducers) that accumulate extracellularly at high cell densities, in a 
process referred to as quorum sensing.  Many types of quorum sensing systems with 
different classes of signaling molecules exist, typically with autoinducers unique to a 
certain organism.  However, the production of a reltively newly discovered signaling 
molecule described as autoinducer-2 (AI-2) is conserved among large numbers of 
pathogenically relevant and phylogenetically diverse species.  This makes AI-2 quorum 
sensing inhibitor development particularly attractive due to the possibility of a broad 
spectrum effect. 
     There were two major goals of this study.  The first was to screen inhibitors of AI-2 
quorum sensing for their effect on biofilm formation in diverse strains and species of 
bacteria.  Although a handful of inhibitors of LuxS (the AI-2 synthase) have been 
developed to date, no data yet exists in the literature of their effect on bacteria.  The 
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second goal was to further understand any observed effects of the quorum sensing 
inhibitors.  For many organisms, the effect of AI-2 on biofilm formation is poorly 
understood, therefore this was investigated by the addition of in vitro synthesized AI-2. 
     The organization of this thesis is described as follows:  Chapter 2 introduces the 
concept of bacterial biofilms, discusses their societal implications, and reviews a number 
of techniques developed to control biofilms; Chapter 3 discusses the different classes of 
known bacterial quorum sensing systems and introduces the AI-2 biosynthesis pathway 
and questions about its chemical identity and interrelationship with metabolism; Chapter 
4 presents a complete review of the literature on AI-2 quorum sensing inhibitors.  
Chapter 5 details the experimental methods; Chapter 6 presents the results of screening i  
vitro synthesized AI-2, LuxS inhibitors, and a brominated furanone against three different 
organisms and discusses implications of the results; and Chapter 7 presents conclusions 
and suggestions for future research. 
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     Bacteria have long been considered to be independent unicellular organisms, and this 
view remains the perception in most basic biology education today.  Although 
observations in the 1930s-40s were documented in which bacteria were found to 
associate with surfaces, it was thought that these wer  isolated examples1.  Beginning in 
the 1970s, studies were conducted which showed that the vast majority of bacteria in 
oligotrophic environments were surface-associated1.  Today the predominance of 
biofilms as the primary state of bacteria in a wide variety of environments, including the 
human body, is now recognized1.     
     Bacterial biofilms consist of live and dead cells immobilized on a surface, usually 
embedded in an extracellular polysaccharide matrix ('slime') that is excreted by the 
bacteria.  The extracellular polysaccharide substance (EPS) often accounts for more of 
the biofilm volume than the cells themselves.  The t ickness of biofilms can range 
anywhere from a sub-monolayer of cells to hundreds of millimeters.  A cross-sectional 
schematic of a typical mature biofilm is shown in Figure 1, however the structure of 
biofilms of individual species and in different environmental conditions can vary 
significantly. 
 
2.2. Societal implications 
 
     In medicine, biofilms play a prominent role as being a major source of infections in 
the human body.  The National Institutes of Health proclaimed in a public announcement 






Figure 1:  Cross-sectional schematic depicting a typical mature biofilm.  A layer of cells covers 
the substrate, and pillars supporting cell clusters encased in extracellular polysaccharide allow the 
formation of channels for convective and diffusive flow of nutrients through the film.  Streamers 
allow maximal contact of biofilm cells with the bulk fluid and are common in Pseudomonas 




body can either occur directly on host tissues, or in association with implanted devices, 
such as catheters, stents, mechanical heart valves, and pacemakers3,4. Examples of 
infections frequently caused by biofilms on host tisues include colitis, vaginitis, urinary 
tract infections, conjunctivitis, otitis, and gingivit s3.  Chronic lung infections caused by 
biofilms of Pseudomonas aeruginosa are the main cause of loss of lung function and 
mortality in patients with cystic fibrosis5.   
     Biofilms also have many negative industrial and e gineering impacts.  The fouling of 
process equipment results in increased fluid frictional resistance due to biofilm-induced 
drag, an increased overall heat transfer coefficient (in the case of heat transfer surfaces), 
and often accelerated rates of corrosion.  The cumulative economic effect includes energy 
losses, increased capital costs for excess equipment capacity and equipment replacement, 
unscheduled downtime due to equipment failures, and scheduled downtime to 
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accommodate fouling removal6.  Estimates on the cost of fouling (including but not 
limited to bacterial fouling) of heat exchangers in the U.S. alone range in the billions of 
dollars6.  It has been approximated that at least 10% of the fuel consumed by Naval 
vessels is used to overcome the increased viscous drag as a result of fouling organisms7.  
Bacterial colonization is generally recognized to render a surface more conducive to the 
settlement of higher organisms, including algae, diatoms, fungi, protozoa, and eventually 
invertebrates such as tubeworms, barnacles, and zebra mussels8.  Furthermore, biofilms 
can either accelerate or decelerate rates of corrosi n.   This is dependent on whether the 
microenvironment they create as a result of their metabolism creates conditions 
conducive to corrosion processes, or passivates a met l surface to protect from further 
corrosion.  Localized potential differences can be caused by oxygen depletion in non-
uniform biofilms, resulting in the flow of corrosion currents9.  Many bacteria secrete 
organic acids such as acetic acid, lactic acid, and succinic acid, which are capable of 
removing some oxide passivation films and therefore p omote increased corrosion9.  
Sulfate-reducing bacteria produce metabolic byproducts including iron sulfide, hydrogen 
sulfide, and sulfuric acid, which can also increase rates of corrosion by various 
mechanisms9. 
     Complicating the control of biofilms for either medical or industrial purposes is their 
inherent resistance to antimicrobial agents, including both antibiotics and biocidal agents.  
Inherent diffusional limitations, particularly of larger molecules such as antibiotics, 
obviously play a role in resistance.  Certain physical properties of the EPS, such as its 
positive charge serving as an adsorbent, may also be a factor10.  Another postulated 
explanation is that the high level of differentiation of cells in biofilms creates many 
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"layers of defense" against antibiotics.  For example, an antibiotic that acts by inhibiting 
growth would not affect non-proliferating regions of the biofilm and thus ensure its 
survival11.  The high level of differentiation also results in alterations to the local 
environment within the biofilm, including reduced pH, which can render many 
antimicrobial agents ineffective10,12.  Genomic and proteomic studies comparing biofilms 
with planktonic cells typically show hundreds of major deviations that would translate to 
significant physiological differences, making a full nderstanding of all the reasons 
behind biofilm resistance an extremely complex task.  Thus the prevention of the onset of 
biofilm formation would, in many situations, be a more desirable outcome. 
 
2.3 Control of biofilms 
 
2.3.1. Strategies for non-medical applications 
 
      In industrial processes, including drinking water trea ment, the most common means 
of controlling biofilms is chlorination13.  Other oxidizing biocides such as ozone, 
hypochlorite (bleach), hypobromite, chloramine, chlorine dioxide, and hydrogen peroxide 
can similarly be used13.  Non-chemical methods include mechanical cleaning a d the use 
of pulsed acoustic devices14.   
     Many biocidal paints have been developed that are used to prevent fouling of surfaces 
by macroscopic organisms in seawater.  These include paints containing organotin 
compounds (eg. tributyltin) and copper ablative coatings designed to slowly release 
copper as the coating erodes.  However, organotins have been found to accumulate in the 
environment and have adverse effects on biological processes, leading to their strict 
control by many international governments and a proposed international ban by 200815,16.  
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Copper has also been found to accumulate in aquatic ecosystems, leading to control by 
some governments16.   
     Numerous treatments that directly attack the extracellular polysaccharide substance 
(EPS) have been attempted to varying degrees of succe s, including the use of chelating 
agents and various enzymes, as tabulated by Xavier et al17. 
 
2.3.2. Strategies for medical implants 
 
     Modification of surface properties is the primary strategy for reducing biofilm growth 
on medical implants.  Surfactants containing a cationic quaternary ammonium head group 
and a long alkyl chain tail have long been used as b ctericidal agents.  Covalently-
coupled coatings developed based on these surfactants greatly reduce the viability of 
numerous bacteria and mixed biofilms of bacteria and yeasts18,19.  Similarly, poly(4-
vinyl-N-alkylpyridinium bromide) functionalized surfaces are also effective at killing 
bacteria on contact, with N-hexylated PVP resulting i  the largest drop in viable cell 
numbers20.  These coatings have the common feature of preserving the flexibility and 
accessibility of the alkyl chain group for penetrating the bacterial cell wall, thereby 
allowing the cationic nitrogen to disrupt the underlying membrane.   
     Other approaches have focused on preventing the initial adhesion of bacteria to a 
surface, or lowering the force of adhesion between bacteria and a surface to facilitate 
removal.  Many physical properties are involved, including surface energy 
(hydrophobicity or hydrophilicity), surface roughness, steric hindrance of surface groups, 
and electrostatic interactions.  Due to speculation hat the initial attachment of bacteria 
may be promoted by the detection of certain adsorbed proteins or carbohydrates, the 
adsorption of these biomolecules may also need to be controlled.  Poly(ethylene glycol)-
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modified surfaces have been shown to greatly reduce bacterial adhesion and protein 
adsorption by providing a steric repulsive barrier21,22.  A covalently-attached 
hyperbranched fluoropolymer-poly(ethylene glycol) (PEG) composite coating was 
developed to combine both the steric repulsive properties of PEG and the low surface 
energy of fluoropolymers23.  This coating was found to reduce the adsorption of various 
proteins and lipopolysaccharides, as well as facilit te the removal of algal sporelings.  A 
novel discovery was the strong biofilm inhibitory activity of a group II polysaccharide 
capsule secreted by a uropathogenic strain of E. coli24.  It was found to strongly quench 
biofilm formation in E. coli, P. aeruginosa, Klebsiella pneumoniae, Staphylococcus 
aureus, Staphylococcus epidermis, and Enterococcus faecalis.  The polysaccharide 
capsules were found to act by electrostatically modifying surfaces and reducing cell 
aggregation.   
 
2.3.3. Strategies for therapeutic drug development 
 
     The methods thus far described would only be us ful in eliminating biofilms from 
industrial and medical implant surfaces.  Specific therapeutic treatments against disease-
causing biofilms in the body are presently virtually non-existent.  Excess iron (Fe3+) salts 
greatly decrease biofilm formation in Pseudomonas aeruginosa and Staphylococcus 
aureus, and disrupt pre-formed biofilms of P. aeruginosa25,26.  Some antibiotics have 
recently been discovered to have anti-biofilm activity, possibly by inhibiting 
exopolysaccharide production.  Azithromycin, a macrolide antibiotic, was found to delay 
biofilm formation in P. aeruginosa at concentrations below its minimum inhibitory 
concentration (MIC), but to have no effect when applied to established biofilms27.  
Similarly, clarithromycin, which is structurally related to azithromycin, inhibited biofilm 
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formation of Mycobacterium avium at a sub-MIC concentration but had no effect against 
established biofilms28.  The screening of a plant compound library resultd in the 
discovery of ursolic acid from Diospyros dendo (an African ebony) as a new class of 
biofilm inhibitor29.  It was shown to inhibit the formation of P. aeruginosa, Vibrio 
harveyi, and E. coli biofilms, and to disperse established biofilms of E. coli.  Ursolic acid 
was proposed to act as a signal to cells to remain otile, based on the upregulation of 
genes related to chemotaxis and motility in E. coli.  Other ursene triterpene compounds 
extracted from Diospyros dendo inhibit biofilm formation in P. aeruginosa by 32 to 62 
percent30.  N-acetyl-L-cysteine has been found to reduce EPS production in many 
bacteria and to reduce adhesion to stainless steel plates, and is already used in the 
treatment of patients with chronic bronchitis31.  A novel class of therapeutic drugs being 
considered for the treatment of biofilms are quorum sensing inhibitors, which are 
discussed in detail in Chapter 4. 
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     Quorum sensing is the process in which bacteria releas  and detect signaling 
molecules and thereby coordinate their behavior in a multicellular manner.  The signaling 
molecules, or autoinducers, are observed to modulate behavior only above a certain 
threshold concentration corresponding to a certain cell population density, or 'quorum'.  
Three distinct types of quorum sensing have been discovered: acyl-homoserine lactone 
(AHL) signaling, which is unique to various species of Gram-negative bacteria; 
autoinducing oligopeptide signaling, which is unique to various species of Gram-positive 
bacteria; and autoinducer-2 signaling, which occurs over a broad range of Gram-positive 
and Gram-negative bacteria.  Other more limited extracellular signaling systems have 
also been found. 
 
3.2. Classes of quorum sensing systems 
 
3.2.1. Acyl-homoserine lactone signaling 
 
     AHL signaling was first described in the bioluminesc nt marine bacteria Vibrio 
fischeri, where it was found that the synthesis of luciferas  (an enzyme responsible for 
light production) was transcriptionally controlled by a phenomenon called 
"autoinduction32."  It was observed that luciferase expression increased during 
exponential growth, although the signaling mechanism by which this occurred was not 
yet understood.  Over a decade later, the autoinducer was definitively isolated and 
identified as N-3-oxo-hexanoyl-L-homoserine lactone (AI-1)33.  In V. fischeri, AI-1 is 
synthesized by LuxI and can freely diffuse across the cell membrane.  The signal receptor 
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protein, LuxR, resides within the cytoplasm and binds with AI-1 to form a multimer 
complex that can bind to a 'lux box' located upstream from the target gene on an operon 
(Figure 2).  RNA polymerase then interacts to stimulate transcription of the target gene34.  
Over 50 species of Gram-negative Proteobacteria have since been found to produce 
AHLs, with most species producing unique molecules that differ in acyl chain length and 
the functional group on the β-carbon of the acyl chain35.  Most regulatory proteins are 
homologues of LuxI and LuxR, although V. fischeri has been found to produce a second 
AHL regulated by a novel AinS-AinR system36.  AinS is similar to LuxM in Vibrio 
harveyi and is also present in Escherichia coli35.  Pseudomonas fluorescens possesses an 
AHL synthase, HdtS, which is also not related to LuxI37.  Although AHLs were originally 
discovered due to their regulation of bioluminescence in Vibrio spp., many different 
target functions are affected in other species.  AHL-mediated target functions in 
Pseudomonas spp. include biofilm formation, protease production, cell aggregation, 
rhamnolipid synthesis, swarming, twitching, and virulence38.  Other regulatory functions 
of AHLs include regulation of exopolysaccharide production by Sinorhizobium meliloti 
and Pantoea stewartii39,40, virulence and exoenzyme production in Erwinia carotovora41, 
and conjugation of the Ti plasmid in Agrobacterium tumefaciens42. 
 
3.2.2. Autoinducing oligopeptide signaling 
 
     Gram-positive bacteria lack AHL quorum sensing systems, but instead synthesize 
autoinducing oligopeptides consisting of between five to seventeen amino acids, 
sometimes with post-translational modifications43.  These oligopeptides are actively 




Figure 2:  Schematic of the LuxI-LuxR acyl-homoserine lactone signaling system35.  AHLs are 
synthesized by LuxI from S-adenosyl-L-methionine (SAM) and fatty acid precursors conjugated 
to an acyl carrier protein (acyl-ACP).  AHLs can freely diffuse across the cell wall and 
membrane.  The cytoplasmic receptor protein, LuxR, forms a multimer after binding to the AHL, 
which interacts with one or more lux boxes upstream from the regulated target gene.  RNA 
polymerase interacts to stimulate transcription of the operon. 
 
 
are detected extracellularly by a sensor kinase, which phosphorylates a downstream 
response regulator protein44.  The phosphorylated response regulator binds to DNA to 
promote the expression of target genes.  Each oligopeptide is unique to a particular 
species, with some species producing several different sequences.  In Staphylococcus 
aureus, various oligopeptides modified with thiolactone rings control the production of 
virulence factors and surface attachment during late exponential growth, presumably to 
allow host invasion43.  In Enterococcus faecalis, the synthesis of gelatinase, a virulence 
factor, is activated by an eleven-residue cyclic peptid  containing a lactone ring45.  
Bacillus subtilis secretes several diverse peptide signaling molecules, including ComX, a 
peptide consisting of ten residues with a post-translational isoprenylation of a tryptophan 
 
 13 
residue, which modulates the control of genetic competence and several other genes as a 
function of cell density43,46.  Sporulation of numerous Gram-positive species, including 
Bacillus subtilis and Streptomyces coelicolor, and the production of bacteriocins 
(antimicrobial peptides) are also controlled by various autoinducing oligopeptide 
mediated quorum sensing systems44,46. 
 
3.2.3. Autoinducer-2 signaling 
 
     In experiments investigating the expression of luminescence by Vibrio harveyi, 
Bassler et al. found that in addition to the AHL signal response system, an additional 
unidentified density-sensing system was present47.  This second system was later 
identified to involve LuxP and LuxQ, which served as detectors of this new, but still 
unidentified, autoinducer named autoinducer-2 due to it being the second autoinducer 
discovered in V. harveyi48.  Surette and Bassler collected cell-free supernatants from 
Salmonella typhimurium and Escherichia coli and found that in the mid-exponential 
growth phase, a substance was produced by S. typhimurium and one strain of E. coli  that 
induced bioluminescence in Vibrio harveyi BB170, a reporter strain that lacks the AI-1 
sensor but retains the AI-2 sensor49.  One strain, E. coli DH5α, was found to not produce 
the signaling molecule, therefore in a subsequent study, a library of V. harveyi BB120 
(wild-type) genomic DNA was transformed into E. coli DH5α to screen for AI-2 activity 
using V. harveyi BB17050.  An open reading frame, named luxS, was ultimately 
discovered that was essential for the production of AI-2 by E. coli DH5α.  The open 
reading frame encoding LuxS was found to closely correspond to YgaG in S. 
typhimurium and E. coli. Use of the BLAST search algorithm (National Center for 
Biotechnology Information, http://www.ncbi.nlm.nih.gov/BLAST/) on fully-sequenced 
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bacteria in the database currently identifies homolgues of luxS in well over 80 species 
spanning a wide variety of both Gram-negative and Gram-positive bacteria.  
Furthermore, AI-2 production has been observed in ma y species using the V. harveyi 
BB170 reporter strain, proving that luxS is translated to a functional protein.  These 
include Bacillus subtilis51, Bacillus cereus52, Bacillus anthracis53, Listeria 
monocytogenes54.55, Listeria innocua56, Streptococcus mutans57, Actinobacillus 
actinomycetemcomitans58, Streptococcus gordonii59, various human oral bacteria60, and 
even several species of hyperthermophilic bacteria61.     
 
3.2.3.1. Autoinducer-2 biosynthesis pathway  
 
     Schauder et al. utilized a genomics approach to deduce the function of LuxS62.  They 
realized that luxS occurs in a three-gene operon in Borrelia burgdorferi, together with 
metK and pfs.  MetK converts methionine to S-adenosylmethionine (SAM), and Pfs 
(methylthioadenosine/S-adenosylhomocysteine nucleosidase) hydrolytically cleaves 
methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH) into either 
methylthioribose (MTR) or S-ribosylhomocysteine (SRH)63.  SAM is used as a methyl 
donor by various methyltransferases, producing SAH as a byproduct.  Because SAH 
potently inhibits the methyltransferases, it is quickly degraded by Pfs to SRH.  An 
enzyme from E. coli, S-ribosylhomocysteinase, had long been known to convert SRH to 
homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), however it had only been 
partially purified and its sequence was unknown64.  Schauder et al. were able to prove 
that LuxS is S-ribosylhomocysteinase by comparing dialysed cell-free extracts from a 
luxS+ strain and a luxS- strain of Salmonella typhimurium62.  SAM, SAH, SRH, and/or 
MTA were added as substrates and AI-2 activity was tested using Vibrio harveyi BB170.  
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Only the addition of SRH resulted in AI-2 activity.  The full AI-2 biosynthesis pathway, 
as a part of the activated methyl cycle, is shown in Figure 3.  Homocysteine produced by 
LuxS as a degradation product of SRH can be recycled back to methionine through either 
MetE or MetH (conserved in nearly all bacteria posses ing LuxS65) by transferring a 
methyl group from tetrahydrofolate66.  Methionine can then be utilized in protein 
synthesis or can be used to reconstruct SAM via a SAM synthase.  In this manner, LuxS 
is an important part of the sulfur recycling pathway.  
 
3.2.3.2. Chemical identity of autoinducer-2 
 
     Schauder et al. argued that DPD is not the final identity of AI-2, due to it not being 
observed in MS or NMR analyses after in vitro synthesis, and because it is a highly 
reactive molecule that undergoes nucleophilic attack62.  They suggested that the true 
identity of AI-2 was a furanone formed by a spontaneous cyclization reaction, based on 
DPD having been shown in a prior study to be an unstable intermediate in the formation 
of 4-hydroxy-5-methyl-3(2H)-furanone (MHF) from pentoses69.  Various furanones, 
including MHF, 4-hydroxy-2,5-dimethylfuranone, homofuraneol, and 4,5-dyhydroxy-2-
cyclopentan-1-one were all found to induce AI-2-like activity, but only at several fold 
higher concentrations than DPD.  The structural identity of enzyme-bound AI-2 was first 
determined by crystallization of V. harveyi LuxP70.  The resulting structure was 
determined to be a furanosyl borate diester (Figure 4).  However in another study, 
structures of compounds produced by in vitro reaction of SAH with cell-free extracts of 
E. coli K-12 MG1655, and exhibiting AI-2 activity with the V. harveyi BB170 bioassay, 







































































































Figure 3: AI-2 biosynthesis pathway as part of the activated methyl cycle.  SAM (S-
adenosylmethionine) is used as a methyl donor and its byproduct is SAH (S-
adenosylhomocysteine).  SAH is converted to Hcy (L-homocysteine) and adenosine in organisms 
that do not have LuxS.  In organisms that have LuxS, SAH is hydrolyzed by Pfs to SRH (S-
ribosylhomocysteine) and adenine.  SRH is then converted by LuxS to Hcy and DPD (4,5-
dihydroxy-2,3-pentadione), the precursor of AI-2.  In organisms with AHL quorum sensing, SAM 
is acylated by LuxI to produce AHLs and MTA (methylt ioadenosine).  MTA is a second 
substrate of Pfs, producing adenine and MTR (methylthioribose).  This figure is adapted from 
Xavier and Bassler67 and Vendeville et al.68. 
 
 
shown by Schauder et al., synthetic MHF was found to induce equivalent luminescence 
in V. harveyi BB170 at a concentration 1000-fold higher than their in vitro synthesized 
AI-2, leading to the conclusion that AI-2 may be a precursor to MHF formation.  In a 
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later report, LsrB, a protein that binds to AI-2 directly in Salmonella typhimurium, was 
crystallized and found to bind a non-borated furanone, (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF, Figure 4)72.  These results have led to the 
currently accepted idea that “AI-2” is in actuality no single molecule, but is manifested 
under varying environmental conditions by different quilibrium forms of DPD.  It is 
likely no coincidence V. harveyi detects a borated furanone, and that boron is relativ ly 
plentiful in seawater, the natural habitat for this bacterial species.  Figure 4 shows 
proposed equilibrium interconversions between AI-2 signaling molecules that are 
recognized by Vibrio harveyi72.  Additionally, dehydration of R-DHMF and S-DHMF 
result in the formation of MHF (not shown in Figure 4).  It is possible that the MHF 
detected by Winzer et al. was ultimately a product of R-THMF dehydration in methanol. 
     Although there is evidence supporting the non-enzymatic, spontaneous conversion of 
DPD to various equilibrium forms of AI-2, a recent study has indicated the presence of 
alternative synthesis pathways73.  A stochastic petri net simulation of metabolic fuxes in 
Escherichia coli revealed that the increased AI-2 activity due to glucose supplementation 
could not be explained by the existing known pathways.  It was concluded that adenosine 
is converted by an unidentified enzyme to a V. harveyi BB170-responsive autoinducer, 
possibly by salvaging a ribose phosphate from adenosine.  DPD isolated from tomato 
plants, which lack LuxS, has been attributed to spontaneous non-enzymatic 
rearrangements and dephosphorylation of D-ribose-5-phosphate and D-ribulose-5-
phosphate74.  DPD was found to be a precursor for MHF production in these plants. 






Figure 4: Equilibrium forms of DPD.  R-DHMF and S-DHMF can also be hydrolyzed to 4-
hydroxy-5-methyl-3(2H)-furanone (MHF), a toxic metabolite.  The furanosyl borate diester (S-
TMHF-borate) was the form of AI-2 first found by crystallization of LuxP in Vibrio harveyi.  
Figure taken from Miller et al.72. 
 
 
3.2.3.3. Behaviors regulated by AI-2 quorum sensing 
 
     The most comprehensive way to investigate regulation of gene expression, although 
not necessarily phenotype, is through the use of DNA microarrays.  DeLisa et al. 
extracted RNA from an E. coli luxS mutant (MDAI2) grown in two different conditioned 
media exhibiting a 300-fold differential in AI-2 activity75.  A total of 242 different genes 
were either induced or repressed, representing 5.6%of the genome of E. coli.  Among the 
functional categories of genes that were affected wre those involved in DNA replication 
and cell division, virulence, biofilm formation, exopolysaccharide formation, cell 
motility, signal transduction, and small molecule mtabolism.  In another study, gene 
expression of an AI-2 positive strain (E. coli K-12) and an AI-2 negative strain (E. coli 
DH5α) were compared76.  Genes for chemotaxis, flagella synthesis, and motility were 
found to be induced by AI-2, and genes for central intermediary metabolism, 
biosynthesis, and transposons were repressed.  In many other species, there exists a lack 
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of concerted genome regulation by AI-2.  Differential gene expression of Porphyromonas 
gingivalis and its luxS mutant indicated that only 1% of its genome is regulated by AI-2, 
suggesting it is not a global regulator in this organism77.  AI-2 mostly repressed genes 
related to stress response.  In a luxS mutant of Salmonella typhimurium, differential gene 
expression in the absence and presence of in vitro synthesized AI-2 indicated that only 23 
genes (out of 1136 open reading frames) were induced or repressed by AI-278.  AI-2 
repressed genes encoding a Fur regulated iron transporter and several virulence-related 
genes.  AI-2 induced several genes that encoded putative cytoplasmic or outer membrane 
proteins.  In a differential gene expression study between Neisseria meningitidis and its 
luxS mutant, only one gene encoding a possible iron siderophore receptor was found to be 
significantly overexpressed by AI-279.  This led to the conclusion that in this species AI-2 
may only be a metabolic byproduct rather than a signal ng molecule.  Further evidence 
supporting this conclusion was obtained with a proteomics analysis, where only three out 
of 1300 protein spots were differentially regulated by in vitro synthesized AI-280.  
Regulation of two of the proteins, identified as MetE and MetF (involved in methionine 
biosynthesis), was attributed to the presence of L-homocysteine with in vitro synthesized 
AI-2.  The third protein was not able to be identified.   
     Many other studies have directly investigated phenotypic or behavioral changes by 
constructing luxS mutants or by directly adding in vitro synthesized AI-2.  The addition 
of 11 µM of in vitro synthesized AI-2 to E. coli K-12 (ATCC 25404), DH5α, and K-12 
MG1655 resulted in 26-fold, 29-fold, and 4-fold increases in biofilm formation relative to 
the negative controls81.  Additionally, E. coli DH5α was found to form less biofilm than 
the strains retaining luxS.  In Actinobacillus actinomycetemcomitans, a periodontal 
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pathogen, leukotoxic activity was induced three-fold by conditioned media exhibiting AI-
2 activity from both A. actinomycetemcomitans and E. coli relative to control media 
containing no AI-258.  The induction of leukotoxin protein was also increased nearly two-
fold by AI-2, and the expression of a uA, a gene encoding a periplasmic iron transport 
protein, was induced eight-fold by AI-2.  Regulation f toxin production by AI-2 has also 
been shown in Clostridium perfringens, with luxS mutants producing greatly reduced 
levels of three different toxins82.  In two Serratia strains, luxS mutants were found to be 
less virulent, with one strain having decreased production of carbapenem (an antibiotic), 
and the other strain having decreased production of pr digiosin (an antibiotic) and 
reduced secretion of haemolysin83.  In Streptococcus mutans biofilms, luxS mutants 
exhibited phenotypic differences, with a granular structure as opposed to the usual 
smooth confluent film in wild types57.  Phenotypic differences in biofilm formation by 
luxS mutants of Streptococcus gordonii were found to be absent in five different media, 
but present in 25% human saliva as less confluent films with tall microcolony 
projections84.  LuxS deficient Bacillus subtilis exhibited delayed biofilm formation, with 
defective pellicle formation and maturation, as well as greatly reduced swarming 
motility51.  LuxS was also found to be critical for the development of aerial colony 
architecture leading to the formation of fruiting bodies in B. subtilis.   
     While the promotion of increased biofilm formation and increased virulence by AI-2 
are common themes, much recent work has shown that these traits are inversely regulated 
by AI-2 in other species.  A luxS mutant of Helicobacter pylori formed twice as much 
biofilm as the wild-type85, and the addition of in vitro synthesized AI-2 greatly decreased 
early biofilm formation by Bacillus cereus52.  Similarly, luxS mutants of Listeria 
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monocytogenes EGD-e have also been found to form increased quantities of biofilm54,55.  
The biofilms of luxS mutants were observed to be thicker but less conflue t than those of 
EGD-e.  Complementation with in vitro synthesized AI-2 in the luxS mutant failed to 
restore the parental strain phenotype, and addition of AI-2 had no effect on biofilm 
formation of the parental strain54. The addition of SRH increased biofilm formation.  
Because a luxS mutant would not be able to degrade SRH, it would experience an 
intracellular accumulation of SRH.  This result is interesting because most investigations 
on luxS mutants did not attempt complementation with in vitro synthesized AI-2, making 
it impossible to distinguish between a depletion of AI-2 or an accumulation of SRH.   
     Despite AI-2 often being referred to as a putative interspecies signaling molecule, very 
few studies have directly investigated the effect of AI-2 or LuxS on cocultures of two or 
more species.  In non-laboratory environments, such as in human dental plaque, hundreds 
of different bacterial species co-exist in complex biofilms.  One study has shown that the 
presence of LuxS in at least one species is required for the formation of mixed biofilms of 
Porphyromonas gingivalis and Streptococcus gordonii, despite unimpaired biofilm 
formation by luxS mutants of either bacteria individually59.  In coculture biofilms of S. 
gordonii and Veillonella atypica,  expression of amyB, a gene encoding an α-amylase, 
was increased in S. gordonii86.  Because V. atypica did not produce detectable AI-2, this 
was attributed to a different diffusible signaling molecule.  However, the possibility that 
V. atypica may be able to detect and uptake AI-2, thereby modulating its gene expression, 
was not considered.   
     In summary, many of the more commonly investigated bacterial behaviors, including 
toxin production, biofilm formation, sporulation, swarming motility, and virulence, are 
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directly affected by either AI-2 or LuxS.  The formation of confluent and/or thick 
biofilms can be regulated in opposite directions by AI-2 or LuxS, often with a strong 
dependence on the growth medium.  Global gene or protein expression may be strongly 
regulated by AI-2 or LuxS, or only a handful of genes may be involved.  Further 
complicating the situation, different bacterial species can interact through AI-2 signaling, 
resulting in unexpected phenotypes in co-cultures. 
 
3.2.3.4. Metabolism and AI-2 quorum sensing 
 
     In Vibrio harveyi, the absence of AI-2 bound to LuxP in the membrane periplasm 
causes the phosphorylation of LuxU by an associated protein, LuxQ48,87.  LuxU then 
passes its phosphate to LuxO, and the phosphorylated LuxO interacts with σ54 (the 
nitrogen-limitation sigma factor) to activate expression of small RNA88.  These small 
RNA destabilize the mRNA that encodes LuxR with the assistance of the Hfq chaperone 
protein89.  LuxR controls the transcription of luciferase, rsponsible for bioluminescence 
in V. harveyi.  This phosphorelay signal transduction pathway has been suggested to 
indicate a true quorum sensing role for AI-2 in Vibrio spp. and other marine bacteria 
possessing LuxP, however this does not appear to be the case in most terrestrial 
bacteria68.   
     The up-regulation of extracellular AI-2 production in Escherichia coli by glucose and 
other phosphotransferase system sugars (including fructose, mannose, and mannitol) was 
recognized even before the identity of AI-2 was revealed49.  In chemostat cultures, the 
production of AI-2 by E. coli was found to depend on oxygenation, temperature, glucose 
concentration, and the addition of various nutrients and substrates90.  It was postulated 
that AI-2 signaling was proportional to the overall metabolic rate, due to AI-2 production 
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per cell being linearly proportional to the growth rate.  The level of AI-2 production and 
uptake in Salmonella typhimurium and Escherichia coli is intricately linked to growth 
conditions through regulation of the lsr operon91,92.  The lsr operon consists of seven 
genes, lsrACDBFGE.  They are analogous to many proteins encoded by the rbs operon, 
responsible for the transport and phosphorylation of rib se93.  The lsrACDB genes encode 
an AI-2 importer complex, and lsrF and lsrG encode proteins for processing of 
internalized AI-2.  The genes l rR and lsrK are found adjacent to the lsr operon but are 
transcribed separately.  LsrK phosphorylates AI-2 internalized by the Lsr ABC-type 
transporter.  LsrR is a repressor of the lsr operon, preventing its transcription until it 
binds with phosphorylated AI-291,92.  In addition to transcriptional regulation by LsrR, the 
lsr operon was also found to be transcriptionally repressed by glyceraldehyde 3-
phosphate and partially repressed by glycerol, as well as an unidentified metabolite 
(believed to be dihydroxyacetone phosphate).  The mechanism of repression is through 
the cyclic adenosine monophosphate (cAMP)-cAMP receptor protein (CRP) complex94.  
Deletion of the entire lsr operon in E. coli does not completely stop the import of AI-2 
into the cell (indicating the existence of a low-affinity transporter), nor does it stop 
transcription from the lsr promoter despite greatly reduced AI-2 importation92,95.  It was 
also found that mutation of rpoS encoding the stationary-phase-specific sigma factor σs 
greatly increases transcription of the lsr operon, indicating that several regulators 
influence transcription of lsrACDBFGE95.  While cAMP-CRP represses the expression of 
the lsr operon in the presence of glucose, it has been foud that luxS is indirectly 
upregulated under these conditions95.  Therefore a general picture emerges, as depicted in 






Figure 5:  Schematic of AI-2 synthesis and uptake in E. coli95.  LsrA, LsrC, LsrD, and LsrB form 
a transporter complex responsible for uptaking most AI-2 into the cell.  Intercellular AI-2 is 
phosphorylated by LsrK.  Phospho-AI-2, when bound to LsrR, derepresses expression of 
lsrACDBFG.  In the absence of glucose or other PTS sugars, cAMP-CRP stimulates expression of 
lsrACDBFG.  In the presence of glucose or other PTS sugars, expression of luxS is indirectly 
upregulated.   
 
 
absence of glucose AI-2 is uptaken.  The similarity of the lsr AI-2 uptake system to the 
rbs system has led to the suggestion that AI-2 has a met bolic function in these species68.  
However, Taga et al. point out that there would be no net energy gain from synthesizing 
and metabolizing the same molecule91.   
     A BLAST search for the protein sequence of LsrR from E. coli K-12 MG1655 in all 
available bacterial genomes reveals homologous sequences not only in Salmonella 
typhimurium, but also in Yersinia spp. (transcriptional regulators), Photorhabdus 
luminescens, Pasteurella multocida, Haemophilus somnus, Sinorhizobium spp., 
Rhizobium spp., Rhodobacter sphaeroides, Desulfovibrio spp., and Brucella spp., which 
are all Gram-negative bacteria.  Interestingly, a BLAST search reveals many Bacillus 
spp. that also have LsrR homologues denoted as trancriptional regulators.  Sun et al. 
tabulate many other Gram-positive Firmicutes with low expectation values for 
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homologues of lsrR from S. typhimurium66.  A BLAST search for the protein sequence of 
LsrK from E. coli K-12 MG1655 also reveals highly conserved homologous sequences in 
most species above, as well as Serratia proteamaculans, an Enterobacter species, 
Shigella dysenteriae, Shewanella woodyi, Thiomicrospira denitrificans, Thermosinus 
carboxydivorans, and many other Gram-negative species with very low expectation 
values.  Bacillus spp. also exhibit LsrK homologues, as well as Clostridium spp., another 
genus of Gram-positive bacteria.  The possibility that many organisms internally process 
AI-2 similarly to E. coli and S. typhimurium remains open.  Conservation of lsrACDB is 
less widespread66.  Notably, Bacillus spp. and Streptomyces spp. appear to be among very 
few Gram-positives having these open reading frames.  Among selected Gram-negative 
species, lsrACDB is largely conserved in Yersinia pestis, Shigella flexneri, Pasteurella 
multicida, Sinorhizobium meliloti, and Agrobacterium tumefaciens.   
     Transcription of lsr is controlled by catabolite repression through cAMP-CRP in E. 
coli and S. typhimurium, raising the question of how the putative lsr operon in Bacillus 
and Streptomyces is controlled. Gram-positive bacteria do not possess cAMP-CRP, with
catabolite repression occurring through the unrelated CcpA regulator96.  In Bacillus 
subtilis, fructose-1,6-phosphate is produced from phosphorylated glucose.  Fructose-1,6-
phosphate then activates HPrK, which phosphorylates HPr at a serine site.  HPr-Ser-P 
then binds to CcpA, resulting in a complex analogous to cAMP-CRP that inhibits the 
transcription of target genes96.  No work is known that studies the interplay between LsrR 
and LsrK homologues, nor CcpA-dependent catabolite repression on AI-2 quorum 
sensing in Gram-positive bacteria.  There have been studies that investigate the effect of 
CcpA on biofilm formation in Gram-positive bacteria,  behavior that is usually AI-2 
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regulated.  A ccpA-deficient mutant of Streptococcus mutans was found to exhibit greatly 
decreased biofilm formation over the wild-type, whereas a luxS-deficient mutant had a 
similar level of biofilm formation to the wild-type.39  A ccpA mutant of Bacillus subtilis 
grown in medium supplemented with 1.0% glucose exhibited greatly increased biofilm 
formation than the wild-type, indicating that CcpA inhibits a gene involved in biofilm 
formation in the presence of glucose97.  If CcpA regulates transcription of the lsr operon 
in a manner similar to cAMP-CRP, then the presence of glucose would repress 
transcription of the transporter genes.  This would prevent the importation of AI-2, 
consistent with luxS mutants of B. subtilis exhibiting delayed and defective biofilm 
formation51. 
 
3.2.4. Other extracellular signaling systems 
 
     Additional extracellular chemical signals used by bacteria include 2-alkyl-4(1H)-
quinolones in Pseudomonas and Burkholderia spp.40,41, and indole in Escherichia coli.42  
A newly discovered signaling molecule called autoinducer-3 has been proposed to 
mediate bacteria-host communication in enteric bacteria.39  The mammalian hormones 
epinephrine and norepinephrine can both bind to the AI-3 receptor and stimulate similar 
responses.43  Furthermore, AI-3 synthesis is downregulated by inactivation of luxS, 
although this is believed to be due to increased flux through an alternative pathway for 









     Bacterial antibiotics typically function by interfering with DNA transcription, RNA 
translation, or with the synthesis or crosslinking of peptidoglycan in the cell wall.  
Overuse and improper use of antibiotics has led to a prevalence of bacterial resistance to 
these chemicals.  This can take the form of increased ability to degrade antibiotics, 
decreased membrane permeability, decreased affinity, or increased efflux103.  As bacterial 
multiresistance increases, new antibiotics need to constantly be developed to meet 
medical needs.  Because quorum sensing modulates the expression of many genes 
necessary for coordinated behaviors related to virulence and pathogenicity, quorum 
sensing inhibitors (QSIs) have been suggested as a new route for antibacterial drug 
development.  QSIs would attenuate gene expression that leads to pathogenic phenotypes, 
rather than having inherent toxic or growth inhibitory properties.  Therefore it would be 
expected that QSIs would exert less evolutionary pressure that could lead to resistance. 
      Much research has been carried out on inhibitors of AHL-based quorum sensing in 
Gram-negative bacteria, particularly Pseudomonas aeruginosa.  These inhibitors are 
typically analogues of AHLs that either competitively bind to LuxR-like receptor 
proteins, or noncompetitive inhibitors that bind to other regions of the receptor protein, 
and are not AHL analogues.  Smith et al. synthesized and tested analogues of an AHL 
produced by P. aeruginosa, 3-oxo-dodecylhomoserine lactone104.  Two analogues, N-
(trans-2-hydroxycyclopentyl)-3-oxododecanamide and N-(2-oxocyclohexyl)-3-oxodo-
decanamide, acted as quorum sensing antagonists, reducing biofilm formation and the 
expression of certain virulence factors.  Geske et al. also synthesized AHL analogues and 
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found three with activity against TraR, the quorum sensing transcriptional regulator in 
Agrobacterium tumefaciens105.  Two of these analogues, containing an indol and  
bromophenyl group on the acyl chain, significantly reduced biofilm density and 
organization in Pseudomonas aeruginosa. 
 
4.2. Inhibitors of autoinducer-2 quorum sensing 
 
     Inhibitors of AI-2 quorum sensing are of particular interest due to the broad range of 
species that could potentially be affected by a single compound.  These inhibitors could 
target enzymes involved in either the production or uptake of AI-2.  However, it appears 
that different bacteria detect and uptake different quilibrium forms of AI-2 through a 
variety of largely unidentified enzymes (although an Lsr transporter complex may be 
relatively widely conserved66).  Therefore, emphasis has so far been placed on inhibitors 
of enzymes in the production pathway.   
 
4.2.1. Inhibitors of SAH/MTA nucleosidase 
 
     SAH/MTA nucleosidase (Pfs) has been considered a target for the design of 
antibacterial agents long before the discovery of AI-2 and knowledge of its role in this 
quorum sensing pathway.  Inhibition of this enzyme results in a build-up of MTA and 
SAH, which at elevated levels are toxic to the cell.  MTA is known to be a potent 
inhibitor of spermidine synthase, which is involved in the synthesis of polyamines106.  
Polyamines are in turn believed to be involved in growth processes and DNA 
synthesis107.  Pfs also plays a part in sulfur metabolism pathwys, with MTR eventually 
being recycled back to methionine, an essential amino acid that requires a large 
expenditure of energy to synthesize107,108.  Finally, SAH buildup results in feedback 
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inhibition of SAM trans-methylation reactions107.  Mammals lack Pfs, and instead 
metabolize MTA with MTA phorphorylase, and SAH with SAH hydrolase109, therefore 
Pfs inhibitors would be expected to specifically target microbes.  Pfs inhibition now has 
added attractiveness due to the reduction of downstream synthesis of AI-2, although it is 
unlikely that attenuation of quorum sensing would be a primary outcome of their usage. 
     Guillerm et al. published the earliest paper in the literature concerning the synthesis of 
proposed inhibitors of Pfs, however no results were published concerning their biological 
activity110.  These compounds were hydroxylated pyrrolidines speculated to be transition 
state analogues (Figure 6A).  Later work turned to analogues of MTA.  Cornell et al. 
synthesized and tested enzyme activity of several alky -substituted and aryl-substituted 
MTA analogues, and also screened other MTA-like comp unds, various nucleosides, 
MTR, and two MTR analogues111.  They found that various aryl substitutions on the
sulfur atom of MTA resulted in enzyme inhibition, with the most potent inhibitor being 
5’-(p-nitrophenyl)thioadenosine (Figure 6B), exhibiting a Ki of 0.02 µM.  MTA 
analogues with fluorinated methyl groups on the sulfur atom were also synthesized and 
tested by, however these had higher inhibition constant  than compounds found in the 
Cornell study112.  Detailed crystallographic information in recent years has elucidated the 
complete structure and geometry of the binding siteof SAH/MTA nucleosidase in 
Escherichia coli, allowing for more rational inhibitor design113.  In one study, hundreds 
of thousands of commercially available compounds were screened against certain binding 
site properties, leading to the discovery of a purine benzylamine derivative having Ki = 1 
µM114.  This molecule adopts an unexpected bound conformation in the binding site, with 
hydrogen bonding between purine nitrogens and binding s te protein residues, and π-π 
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stacking with a phenylalanine residue.  This led to ligand studies on a non-optimal 
portion of this molecule, resulting in the discovery of two compounds with nanomolar Ki
values (Figure 6C).  In another study, screening of commercially available compounds 
led to the consideration of 5-nitroindazole115.  With this starting point, numerous 3,5,7-
trisubstituted indazoles containing C5 aryl sulfonamides were synthesized.  Several 
compounds were discovered with nanomolar Ki values, with 3’,4’-dichloro-biphenyl-3-
sulfonic acid (3-chloro-7-isobutylamino-1H-indazol-5-yl)-amide (Figure 6D) having the 
highest potency.  Very recently, femtomolar Ki compounds have been synthesized that 
are analogues of the transition state, rather than of the substrate or products116.  The most 
potent inhibitor from this study is (3R,4S)-4-(4-chlorophenyl-thiomethyl)-1-[(9-
deazaadenin-9-yl)methyl]-3-hydroxypyrrolidine (Figure 6E).  Another recent study 
discusses the synthesis of a SAH/MTA nucleosidase inhibitor with a Ki of 1.7 nM
117.  
This compound, 2-amino-4-[5-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-
dihydroxypyrrolidin-2-ylmethylsulfanyl]-butyric acid (Figure 6F), is nearly identical to 
one of the proposed inhibitors from Guillerm et al., with the exception of containing an 
adenine ligand.  No reports have been published concerning the effect of any Pfs inhibitor 
against bacteria. 
    
4.2.2. Inhibitors of S-ribosylhomocysteinase 
 
     Far fewer studies have targetted S-ribosylhomocysteinase (LuxS) for the development 
of inhibitors.  The only known functions of this enzyme are the synthesis of DPD, SAH 
detoxification, and possibly a minor role in the sulfur recycling pathway.  Thus it serves 
as a less broad-spectrum target for antimicrobial drug development than Pfs.  However, 












































































Figure 6: Chemical structures of inhibitors of SAH/MTA nucleosidase. (A) hydroxylated 
pyrollidines speculated to be enzyme inhibitors110; (B) 5’-(p-nitrophenyl)thioadenosine with a Ki
of 0.02 µM111; (C) purine benzylamine derivatives with Ki of 0.043 µM (top) and 0.0028 µM 
(bottom)114; (D) indazole sulfonamide derivative with Ki of 0.0016 µM
115; (E) transition state 
analogue with Ki of 47 fM




sensing, likely without a significant effect on bacterial growth.  This could be of 
particular interest in controlling gene expression in industrial fermentation processes.  For 
example, it could be desirable to prevent a culture from sensing that it has reached a high 
density in order to prolong the transition to the stationary phase.  Additionally, 
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recombinant protein fusions could be designed as part of an artificial AI-2 quorum 
sensing circuit118 that exhibit tunable expression through the use of inhibitors of LuxS. 
     Zhao et al. tested SRH analogues for inhibitory activity against S-
ribosylhomocysteinase, including S-ribosylthiobutyric acid, 5-methylthioribose, 5-
(trifluoromethyl)thioribose, and 5-(4-nitrophenyl)thioribose119.  All of these compounds 
introduced ligands to the sulfur atom, and resembled earlier discovered inhibitors of Pfs 
without the adenine group.  It was found that none f these compounds had any activity 
against S-ribosylhomocysteinase, and it was postulated that the amine in the 
homocysteine residue on SRH is critical for binding to the active site.  The catalytic 
mechanism of the enzyme was determined by Zhu et al.120.  It was found that S-
ribosylhomocysteinase catalyzes three distinct reactions, and knowledge of the 
mechanism enabled subsequent rational inhibitor design.  Alfaro et al. developed two 
inhibitors, S-anhydroribosyl-L-homocysteine, and S-homoribosyl-L-cysteine (Figure 
7A)121.  S-anhydroribosyl-L-homocysteine (SARH) was shown to be a very weak 
inhibitor of LuxS.  The addition of 100 µM of S-homribosyl-L-cysteine nearly 
completely quenched the reaction of either 0.34 µM LuxS or 3.4 µM LuxS with 100 µM 
of SRH.  The Ki was not determined, but it is likely in the high µM to mM range for this 
compound.  The most recent study reporting inhibitors f S-ribosylhomocysteinase 
involved the synthesis of analogues of an intermediat  during the catalyzed reaction122.  
Two diastereomeric compounds (Figure 7B), (2S)-2-amino-4-[(2R,3S)-2,3-dihydroxy-3-
N-hydroxycarbamoylpropylmercapto]butyric acid (Pei compound 10), and (2S)-2-amino-
4-[(2R,3R)-2,3-dihydroxy-3-N-hydroxycarbamoyl-propylmercapto]butyric acid (Pei 
compound 11) were found to have sub-micromolar Ki values against certain forms of 
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LuxS.  The Ki values of Pei compounds 10 and 11 are shown in Table 1 against LuxS 
from Bacillus subtilus, Escherichia coli, and Vibrio harveyi with the stated center metal 
ions.  Lineweaver-Burke plots verified that these compounds inhibit LuxS competitively. 
     Despite all of this work to synthesize and characterize the in vitro activity of inhibitors 






































Figure 7: Chemical structures of inhibitors of S-ribosylhomocysteinase. (A) S-anhydroribosyl-L-
homocysteine (top) and S-homoribosyl-L-cysteine (bottom)121; (B) transition state analogue 





Table 1: Inhibition constants of Pei compounds 10 and 11 against LuxS from  
different bacterial species with the stated coordinated metal ions46. 
 
Enzyme Coordinated Ki (µM)  
 metal ion Pei 10 Pei 11  
   
E. coli LuxS Co2+ 3.2 ± 0.3 12.7 ± 0.4 
V. harveyi LuxS Co2+ 9.7 ± 0.4  12.8 ± 0.3     
B. subtilis LuxS Co2+ 0.72 ± 0.02 0.37 ± 0.04 
 Fe2+ 0.72 ± 0.03 0.43 ± 0.02 








4.2.3. Brominated furanones 
 
     In addition to direct inhibitors of enzymes in the AI-2 biosynthesis pathway, another 
possible class of inhibitors are the halogenated furanones first isolated from Delisea 
pulchra, a red alga which was observed to have a biofilm-free surface123.  These 
compounds have structural similarity to AHLs, and argu bly also have a similarity to 
certain equilibrium forms of AI-2.  Many studies have been conducted that demonstrate 
interference with AHL quorum sensing on addition of brominated furanones (most 
studies utilize (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone, Figure 8) 
from Delisea pulchra, including: inhibition of swarming motility in Proteus mirabilis124; 
reduced binding of tritiated N-3-(oxohexanoyl)-L-hom serine lactone to LuxR in E. 
coli125; reduced bioluminescence and toxin production by Vibrio harveyi126; and 
repression of lasB expression, reduced virulence factor production, decreased biofilm 
antibiotic resistance, and altered biofilm architecture leading to increased biofilm 
detachment in Pseudomonas aeruginosa127,128.  The brominated furanone in Figure 8 has 
also been shown to repress siderophore synthesis in P eudomonas putida and to induce 
siderophore synthesis in P. aeruginosa129. 
    Brominated furanones derived from Delisea pulchra have also been found to directly 
inhibit AI-2 quorum sensing independently from AI-1 quorum sensing in Vibrio harveyi, 













possess an AI-2 quorum sensing system130.  A microarray study of E. coli grown in the 
presence or absence of 60 µg mL-1 of brominated furanone or in vitro synthesized AI-2 
showed that the brominated furanone repressed 79% of the genes induced by addition of 
in vitro AI-2, although only a handful of genes repressed by AI-2 were induced by the 
brominated furanone76.  The repressed genes were primarily related to chemotaxis, 
flagella synthesis, and motility.   Brominated furanones also have broad-spectrum 
antimicrobial activity against many Gram-positive bacteria which lack AHL quorum 
sensing systems.  Brominated furanones have been fou d to quench growth in a 
concentration-dependent manner in Bacillus subtilis and Bacillus anthracis, reduce 
swarming and biofilm formation in Bacillus subtilis, and reduce expression of three 
different virulence genes in Bacillus anthracis131,132.  In Staphylococcus aureus and 
Staphylococcus epidermis, they have been demonstrated to quench growth while having 
no effect on cultured mouse cells133.  To date, no direct evidence has been published tat 
definitively links the activity of brominated furano es to AI-2 quorum sensing in Gram-
positive bacteria.   
     Despite the murky connection to quorum sensing, brominated furanones have proven 
to be surface active compounds capable of directly preventing biofilm formation on 
substrates.  Various polymer surfaces with physically adsorbed furanone were shown to 
have reduced bacterial loading and slime production in Staphylococcus epidermis134.  
Another study incorporated furanone into polystyrene disks, and also used crosslinking 
procedures to covalently bind the furanone onto catheters135.  Bacterial load of 
Staphylococcus epidermis was decreased on the polystyrene-furanone disks.  Furanone-
coated catheters exhibited lower bacterial counts, and those implanted into sheep resulted 
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in lower-grade infections than control catheters for up to 65 days.  None of these studies 
has speculated on the mechanism of action of surface-bound furanones, however it is 
possible that all studies conducted to date are actually testing furanone in a surface active 
state.  Brominated furanones are not soluble in aqueous solution, and quickly precipitate 
as visible particles when a small amount of dissolved furanone in a non-aqueous solution 
is added to bacterial media.  These furanone particles an also be observed to 
spontaneously coat the polystyrene used in most biofilm formation assays.  One 
possibility is that the furanones act on receptor pr teins on the cell membrane, including 
quorum sensing molecule receptor sites, and do not need to enter the cell. 
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     The bacterial strains used in this study and their sources are listed in Table 2.  Luria 
broth base, brain heart infusion, marine broth, nutrien  broth, and vitamin assay casamino 
acids were obtained from Becton Dickinson (Cockeysville, MD).  Tryptic soy broth, 
thiamine (hydrochloride), riboflavin, L-arginine, D-(+)-glucose (anhydrous, mixed 
anomers), imidazole (approximately 99%), isopropyl β-D-1-thiogalactopyranoside, 
adenine, S-adenosyl-L-homocysteine, and Dulbecco's phosphate buffered saline 
(modified, without CaCl2 and MgCl2) were purchased from Sigma (St. Louis, MO).  
Crystal violet (high purity biological stain) and glycerol (99+%) were purchased from 
Acros Organics (Geel, Belgium).  Magnesium sulfate (anhydrous), potassium chloride 
(ACS reagent), potassium phosphate dibasic (anhydrous, ACS reagent), potassium 
phosphate monobasic (ACS reagent), sodium citrate, zinc acetate, Tris (crystallized free 
base, molecular biology grade), ampicillin sodium salt (biotech grade), HPLC grade 
water, and chloroform (ACS reagent) were purchased from Fisher Scientific (Fair Lawn, 
NJ).  Sodium chloride, sodium hydroxide (pellets, ACS reagent), concentrated 
hydrochloric acid, and acetonitrile (Baker analyzed HPLC solvent) were purchased from 
J. T. Baker (Phillipsburg, NJ).  Absolute ethanol (anhydrous, USP grade, ACS reagent), 
95% ethanol (USP grade, ACS reagent), and acetone (ACS reagent) were purchased from 
Pharmco-Aaper (Brookfield, CT).  DL-homocysteine (purum, >95.0%) was purchased 
from Fluka (Buchs, Switzerland).  Phosphate buffered saline (PBS) was prepared by 
dissolving 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, and 0.24 g KH2PO4 in deionized water 
to a final volume of 1 L, adjusting to pH 7.4 with 5 N HCl, and autoclaving at 121°C for 
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25 minutes.  S-anhydroribosyl-L-homocysteine (SARH) was obtained from Dr. Sunny 
Zhaohui Zhou at Washington State University.  A 10 mM stock solution of SARH was 
prepared in PBS.  Pei compounds 10 and 11 were obtained from Dr. Dehua Pei at Ohio 
State University.  Stock solutions were prepared containing 1 mM of each inhibitor in 
PBS.  The brominated furanone in Figure 8 was obtained from Dr. Thomas Wood at 
Texas A&M University at a concentration of 32.25 mg/ L in 95% ethanol. Inhibitor 
stock solutions were 0.22 µm filter-sterilized and stored at either 4˚C (brominated 
furanone), -20˚C (SARH), or -80˚C (Pei compounds 10 and 11).   
 
5.2. Bacterial cell culture 
     The bacterial strains and plasmids used in this study are listed in Table 2.  Escherichia 
coli DH5α stock was originally obtained from Dr. Thomas Wood at Texas A&M 
University.  Strains obtained as freeze-dried cultures from American Type Culture 
Collection (ATCC) were revived overnight according to the provided instructions.  The 
following day, the overnight culture was used to inculate 50 mL of fresh medium in 250 
mL flasks, and cultures were grown to the exponential growth phase (OD600 of 0.3 to 0.6) 
at 250 rpm and the appropriate temperature on a Certomat BS-1 air shaker (B. Braun 
Biotech, Edgewood, NY).  The culture was then aliquoted into cryogenic tubes and a 
filter-sterilized 40% (v/v) aqueous glycerol solution was added to bring the glycerol 
concentration up to 25% (v/v).   
     Luria-Bertani (LB) medium contained 10 g/L tryptone, 5 g/L yeast extract, and 5 g/L 
sodium chloride, and was prepared according to the manufacturer's instructions from 
Luria broth base.  Brain heart infusion (BHI) medium contained 37 g/L of brain heart 
infusion.  Tryptic soy broth medium (TSB) was prepared with 30 g/L of tryptic soy broth.  
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LB, BHI, and TSB media containing 0.2% (w/v) D-glucose, and two-fold diluted and ten-
fold diluted LB (12.5 g/L, 2.5 g/L) and TSB (15 g/L, 3 g/L) with and without 0.2% (w/v) 
D-glucose were also prepared.  Autoinducer bioassay (AB) medium was prepared by 
dissolving 17.5 g NaCl, 6.0 g MgSO4, and 2.0 g vitamin assay casamino acids per 1 L of 
deionized water, autoclaving for 30 minutes at 121˚C, and allowing to cool.  To 500 mL 
of this solution, 5 mL of filter-sterilized 1 M potassium phosphate solution, 5 mL of 
filter-sterilized 0.1 M L-arginine, 10 mL of autoclaved glycerol, 0.5 mL of filter-
sterilized 10 µg/mL riboflavin, and 0.5 mL of filter-sterilized 1 mg/mL thiamine were 
added.  Marine broth was prepared according to the provided instructions. 
 
Table 2: Bacterial strains and plasmids used in this study. 
 
Strain/plasmid Relevant genotype and property  Source or   




     W3110 Wild-type Laboratory stock 
     DH5α luxS- strain  Laboratory stock     
     K-12 Wild-type ATCC 25404 
     NC13 RK4353∆pfs(8-226)::Kanr Laboratory stock 
Vibrio harveyi 
     BB170 BB120 luxN::Tn5 (sensor 1-, sensor 2+) Laboratory stock 
     MM30 BB120 luxS::Tn5 ATCC BAA-1120 
Bacillus cereus Biofilm-forming strain (isolated from spoiled chees) ATCC 10987 
Listeria innocua Isolated from cabbage ATCC 51742 
Pseudomonas fluorescens Isolated from lactate-enriched water ATCC 17552 
 
Plasmids 
     pTrcHis-Pfs-Tyr pTrcHisB derivative, W3110 pfs+, Ampr Ref. 136 




5.3. Recombinant enzyme purification 
     E. coli DH5α containing the p6His-Pfs-5Tyr plasmid constructed from pTrcHisB 
(Invitrogen), and E. coli pfs null-mutant strain NC13 (genotype RK4353∆pfs(8-
226)::Kanr) containing the p6His-LuxS-5Tyr plasmid constructed from pTrcHisC 
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(Invitrogen) were originally constructed in this laboratory as described by Fernandes et 
al.136.  For each strain, 10 mL culture tubes containing 2 mL of LB medium and 5 µL of 
20 µg/mL ampicillin were inoculated with a scrape of cryogenically frozen stock, and 
grown overnight at 37˚C and 250 rpm in an air shaker.  The next day, cultures were 
scaled up by adding 5 mL of the overnight culture to 95 mL of LB medium with 100 µL 
ampicillin in a 500 mL flask.  The following day, the culture was scaled up again by 
adding 100 mL of the prior culture to 1400 mL of LB medium with 1.5 mL of ampicillin 
in a 3 L flask.  The scaled-up culture was grown to an OD of 0.4 to 0.7 and induced with 
1.5 mL of 1 M IPTG.  After induction, the cultures were grown for another 4-6 hours at 
37˚C and 250 rpm.  The cells were centrifuged at 4500 rpm at 4˚C into pellets and frozen 
at -20˚C after discarding the supernatant.   
     To purify the histidine-tagged enzymes, the frozen cell pellets were resuspended in 30 
mL of PBS with 10 mM imidazole, pH 7.4, and aliquoted into tubes containing no more 
than 10 mL of suspension each.  Each tube was sonicated for 10 min using a sonic 
dismembrator (Fisher Scientific 550) at a power setting of 4.5, with 0.5 s on/off pulses, to 
lyse the cells.  The cell lysate was removed by centrifuging each tube for 15 minutes at 
10000 g and 10˚C, and again for 10 minutes at 14000 g and room temperature after 
aliquoting into 1.5 mL centrifuge tubes.  The cell lysate was collected, and the cell pellets 
were combined and resuspended in 10 mL of PBS with 10 mM imidazole.  The 
suspension was sonicated and centrifuged as before, with the cell lysate collected.  The 
cell pellet was then resuspended in 5 mL of PBS with 10 mM imidazole, sonicated, and 
centrifuged, with the cell lysate collected again.  All clarified cell lysates were combined 
and filtered through a 0.22 µM PES filter (low protein binding, Corning).  
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     A HiTrap Chelating IMAC column (5 mL volume, GE Healthcare, Piscataway, NJ) 
chelated with Ni2+ was equilibrated with 3 column volumes of dilute washing buffer (20 
mM potassium phosphate, 250 mM sodium chloride, 10 mM imidazole, pH 7.4) at a flow 
rate of 4 mL/min with a peristaltic pump (Watson Marlow 505Du), before loading the 
cell lysate at 2 mL/min.  The column was then washed consecutively with three column 
volumes of dilute washing buffer at 2 mL/min, and three column volumes of a second 
washing buffer (20 mM potassium phosphate, 250 mM sodium chloride, 50 mM 
imidazole, pH 7.4).  Next, three columns of elution buffer (20 mM potassium phosphate, 
250 mM sodium chloride, 350 mM imidazole, pH 7.4) was loaded at 2 mL/min.  Only the 
first 8 mL of eluant was collected, and dialyzed (SpectraPor 2 membrane, 12 to 14 kDa 
MWCO, Spectrum Laboratories, Rancho Dominguez, CA) overnight at 4°C into 2 L of 
Dulbecco’s modified PBS.  The dialysate was aliquoted and frozen with 33% glycerol at 
-80˚C.   
     To determine the concentration of each enzyme, the absorbance was measured at 280 
nm in a quartz cuvette.  Molar absorption coefficients for His-Pfs-Tyr and His-LuxS-Tyr 
were approximately calculated from a weighted sum of the number of tyrosine, 
tryptophan, and cysteine amino acid residues present in each enzyme, and were found to 
be 0.708 mL mg-1 cm-1 and 1.00 mL mg-1 cm-1 for His-Pfs-Tyr and His-LuxS-Tyr, 
respectively.  The concentration of enzyme in mg/mL was taken to be the absorbance at 
280 nm divided by the extinction coefficient in mL mg-1 cm-1. 
 
 
5.4. In vitro synthesis of AI-2 and SRH 
 
     Using the calculated enzyme concentrations, Hi-Pfs-Tyr and His-LuxS-Tyr (for AI-
2), or only His-Pfs-Tyr (for SRH) were added to tubes to bring the final concentration to 
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100 µg/mL of each in 0.5 mL final volume.  Enough PBS was added to bring the volume 
to 0.5 mL.  The enzyme reaction was started with the addition of 0.5 mL of 1 mM S-
adenosyl-L-homocysteine in 50 mM Tris buffer at pH 7.8.  Tubes were shaken at 37˚C, 
250 rpm for 4 hours.  The reaction was terminated by the addition of 0.75 mL of 
chloroform.  After vortexing, tubes were centrifuged at 5000 g for 5 minutes.  
Approximately 0.75 mL of the top water layer in each tube was pipetted into a new tube, 
and 0.22 µm filter-sterilized.  Solutions were used in the biofilm formation assay 
immediately after synthesis, without freezing.  Samples were stored at -20˚C for later 
analysis to verify activity with the autoinducer-2 activity assay, and conversion by HPLC.   
 
5.5. High performance liquid chromatography 
     To verify conversion of SAH to SRH and ultimately to DPD, all in vitro AI-2 and 
SRH samples were analyzed by normal phase HPLC on a silic  column (Waters 
Spherisorb, 5 µm particle size, 15 cm x 3.2 mm) with e her 0.5 mL/min or 1.0 mL/min 
of 30% water and 70% acetonitrile.  The injected loop volume was 5 µL.  A UV detector 
at the column outlet recorded intensity at 210 nm (at which only SAH and adenine are 
UV-active) and 260 nm (at which SAH, SRH, and adenin  are UV-active).  Samples 
containing only SAH, adenine, or SRH and adenine were included in each run due to 
drifts in retention time with this method. 
 
5.6. Autoinducer-2 activity assay 
 
     V. harveyi BB170 (a reporter strain for AI-2 that lacks the AI-1 sensor) was inoculated 
with one loop from a cryogenic tube into 2 mL of AB medium and shaken overnight in 
an air shaker at 30˚C, 250 rpm in dark conditions.  The next day, the culture was diluted 
5000:1 in AB medium.  To each 20 µL sample volume, 180 µL of diluted BB170 culture 
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was added.  AB medium was used as a negative control, and for appropriate experiments, 
in vitro synthesized AI-2 was used as a positive control.  In experiments where cell-free 
supernatants were samples, negative controls also included autoclaved medium or 
nutrient-depleted medium.  Samples inoculated with BB170 were shaken at 250 rpm in 
an air shaker, and luminescence measurements were taken every half hour to hour in a 
luminometer (EG&G Berthold Junior).  Nutrient-depleted media were prepared by 
growing Vibrio harveyi MM30 in AB medium overnight at 30˚C with agitation (250 
rpm).  The culture was aliquoted into 1.5 mL centrifuge tubes and centrifuged for 10 
minutes at 4500 g.  The supernatant from each tube was decanted, and cells were 
resuspended in the cell free supernatant plus the addition of a 1:3 ratio by volume of 
medium containing 50 g/L NaCl, 24 g/L MgSO4, 40 mM potassium phosphate, and 10 
mL per L of 0.4 M L-arginine.  This addition of this media supplement served to mimic 
salt concentrations and L-arginine content in AB medium.  Cells were incubated at 30˚C 
for 16 h with agitation (250 rpm).  V. harveyi MM30 (luxS deletion mutant of BB120) 
was removed by centrifuging for 10 minutes at 13800 g, followed by 0.22 µm filter-
sterilizing of the supernatant.  Samples were frozen at -20˚C until thawing for analysis as 
described above.   
 
5.7. Biofilm formation assay 
 
     Culture tubes containing 3 mL of the appropriate medium were inoculated with one 
loop from cryogenic tubes, and grown overnight at the appropriate temperature in an air 
shaker at 250 rpm.  The next day, the OD of the overnight culture was taken and the 
number obtained was used to dilute to an OD of 0.05.  The OD 0.05 cultures were 
aliquoted into 5 mL culture tubes, to which in vitro AI-2 or different concentrations of 
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inhibitors were added.  In experiments involving the addition of in vitro AI-2, the amount 
of buffer added (1:1 PBS/50 mM Tris) was the same for all tubes (except where noted).  
Negative controls for these experiments were the addition of buffer alone, and the 
addition of adenine and DL-homocysteine to a final concentration of 50 µM adenine and 
100 µM DL-homocysteine (only L-homocysteine is present in in vitro AI-2 samples).  In 
experiments involving the addition of quorum sensing i hibitors, equivalent amounts of 
PBS or 95% ethanol were added to all tubes, and negativ  controls contained only PBS  
or 95% ethanol.  The contents of each tube was aliquoted into wells in non-treated 
polystyrene 96 well plates (Corning Costar 3370), with 300 µL added to each well (only 
200 µL was used for Pseudomonas fluorescens).  Plates were incubated without shaking 
at specified temperatures for specified times.  Prior to analyzing the plates for biofilm, the 
optical density of non-disturbed wells was taken as a measure of bulk growth.  The plates 
were then rinsed in a gentle stream of deionized water three times and blotted on paper 
towels.  Each well was stained by the addition of 300 µL of 0.1% (w/v) crystal violet 
solution.  After 20 minutes, plates were rinsed three times in a gentle stream of deionized 
water and blotted dry.  Biofilm-associated crystal violet was solubilized with 95% 
ethanol, or 80% ethanol/20% acetone for Bacillus cereus.  The OD595 of each well was 
measured using a plate reader (Dynex MRX, Chantilly, VA).   
 
5.8.  Statistics 
 
     Sample standard deviations were calculated for all sets of replicate data about the 
mean value.  When one set of data with an average vlu  of x and a standard deviation ∆x
was normalized with another set of data with an averag  value of y and a standard 
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Chapter 6:  Results and Discussion 
 
 
6.1. Optimization of conditions for biofilm formation 
 
     Because the ultimate goal of this work was to identify quorum sensing inhibitors that 
reduce biofilm formation, an initial screening was performed to quantify the effect of the 
addition of in vitro synthesized AI-2 on biofilm formation in all bacterial species and 
strains investigated in this study.  However, in order to obtain meaningful results from the 
96-well biofilm assay, growth conditions first needd to be established that promoted 
biofilm growth significant enough to detect colorimetric differences from crystal violet 
staining.  Due to previous experiments performed in our laboratory, it was known that LB 
medium was suitable for biofilm growth in Escherichia coli.  Additionally, it has been 
previously reported that LB medium supplemented with 0.2% glucose resulted in the 
most biofilm formation in E. coli JM10976.  However, little to no information existed on 
optimal conditions for biofilm formation in Listeria innocua and Bacillus cereus.  A 
series of dilutions of different rich media, supplementation with glucose and yeast 
extract, and different temperatures were tested (Figures 9 and 10).  For Listeria innocua, 
it was found that biofilm formation was greatest when grown at 23°C in BHI medium 
supplemented with 0.2% glucose.  For Bacillus cereus, it was clear that nutrient depletion 
was favorable for biofilm formation, with two-fold iluted LB medium resulting in the 
most biofilm formation.  Therefore for all subsequent biofilm formation assays of L. 
innocua and B. cereus were conducted with BHI supplemented with 0.2% glucose at 
room temperature, and two-fold diluted LB medium at 30-32°C, respectively.  
Additionally, because the effect of glucose was of interest, BHI medium without added 
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glucose and two-fold diluted LB medium supplemented with 0.2% glucose were also 



















































Figure 9:  Listeria innocua biofilm formation after 48 h growth at 23°C and 37°C (TSB, tryptic 
soy broth; TSBYE, TSB supp. with 0.6% yeast extract; BHI, brain heart infusion medium; 2X, 
two-fold diluted; 10X, ten-fold diluted; glu, supplemented with 0.2% glucose).  Error bars 
represent standard deviations about the mean of five to six replicate wells. 
 
 
6.2.  In vitro synthesis of AI-2 
 
     In vitro synthesis of all AI-2 used in biofilm formation ass ys was performed on the 
day that plates were inoculated.  All batches of AI-2 used for biofilm formation assays 
were characterized by HPLC to determine the conversions of SAH to SRH and adenine.  
Although SRH is detectable by HPLC at 260 nm, the peak area varies considerably due to 
its small size and baseline interference, making quantitation of SRH conversion difficult.  
Examples of HPLC chromatograms obtained are shown in Figure 11.  Additionally, each 
batch was tested for its ability to induce bioluminescence in Vibrio harveyi BB170.  
Table 3 lists the fold induction of bioluminescence, d fined as the relative light units 



















































Figure 10:  Bacillus cereus biofilm formation after 48 h growth at 23°C and 32°C (LB, Luria-
Bertani medium; TSB, tryptic soy broth; 2X, two-fold diluted; 10X, ten-fold diluted; glu, 
supplemented with 0.2% glucose).  Error bars represnt tandard deviations about the mean of 
five to six replicate wells. 
 
the conversions of SAH and SRH based on the respective peak areas.  All biofilm 
formation assay results involving the addition of AI-2 are annotated with a letter 
representing the sample used from Table 3.  Althoug there was insufficient quantity of 
sample 'C' for analysis, it was synthesized identically to other samples in Table 3. 
 
Table 3:  Characterization of in vitro synthesized AI-2 samples used in biofilm formation assays.  
Fold induction of V. harveyi bioluminescence are the relative light units (RLU) of the sample 
divided by the RLU of the negative control at the time of their maximum difference (5 h).  
Percent conversion of SAH was determined by HPLC from the adenine peak area. 
 
 AI-2 Sample  Fold induction of V. harveyi        Percent conversion  
             bioluminescence              SAH to SRH  
 A    1266         100% 
 B    4216           100%    
 C    Not analyzed       Not analyzed   
 D    1152           100% 
    E    706             100% 
 F    17012         82% 
 G    12279         80% 
 H    2971           100% 
 I    7622           75%    
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Figure 11:  HPLC chromatograms of 0.5 mM SAH at 260 nm (top); 0.5 mM adenine at 260 nm 
(second from top); 0.5 mM in vitro synthesized SRH at 210 nm and 260 nm, which contains 
adenine as a reaction product (third from top); and0.5 mM of in vitro synthesized AI-2 at 260 
nm, which also contains adenine and homocysteine as r action products (bottom).   
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6.3.  Effect of in vitro synthesized AI-2 on biofilm formation 
 
     In order to understand the results obtained from screening AI-2 quorum sensing 
inhibitors, it is useful to characterize how AI-2 affects biofilm formation under the 
selected sets of growth conditions. 
     The effect of in vitro AI-2 on biofilm formation in E. coli was tested to verify that the 
96 well format of the biofilm assay produced similar results to those obtained previously 
in this group using culture tubes (unpublished data).  Results of independent experiments 
are shown for W3110, DH5α, and K-12 in Figure 12, and for W3110 and DH5α in Figure 
13 (with improved controls and glucose supplementation).  An AI-2 concentration-
dependent increase in biofilm is observed for E. coli W3110 and E. coli K-12.  For E. coli 
W3110 grown in LB medium, AI-2 stimulates a 1.8-fold increase in biofilm over the 
negative control containing a similar concentration of adenine and homocysteine, and a 
2.4-fold increase in biofilm over the control when grown in LB medium supplemented 
with 0.2% glucose.  Similarly, for E. coli DH5α, a 1.6-fold increase in biofilm is 
observed in LB medium, and a 2.3-fold increase in LB medium supplemented with 0.2% 
glucose.  Glucose increases AI-2 production in E. coli through indirect stimulation of 
luxS expression95.  Meanwhile, cAMP-CRP represses transcription of the lsr operon in 
the presence of glucose, delaying import of AI-2 until glucose is depleted upon reaching 
the stationary phase.  This may account for the magnified effect of glucose on biofilm 
formation with the addition of AI-2 that is observed in W3110, as the level of 
extracellular AI-2 is expected to be heightened.  In DH5α, which lacks luxS, additional 
glucose reduces biofilm formation relative to LB medium alone.  This is  possibly due 































20X diluted AI-2 (~25 µM)
10X diluted AI-2 (~50 µM)
 
Figure 12:  Effect of AI-2 on biofilm formation of E. coli strains W3110, DH5α, and K-12 after 
48 h growth in LB medium in 96 well plates at 37°C.  ontrol wells contained the same quantity 
of buffer as wells containing AI-2, but did not contai  adenine or homocysteine.  AI-2 was 
sample "A" in Table 3.  Error bars represent standard eviations about the mean of six replicate 


























50 µM adenine, 100 µM DL-homocysteine
10X diluted AI-2 (~50 µM)
 
Figure 13:  Effect of AI-2 on biofilm formation of E. coli strains W3110 and DH5α after 50 h of 
growth at 37°C in LB medium and LB supplemented with 0.2% glucose.  AI-2 was sample "B" in 
Table 3.  Error bars represent standard deviations about the mean of six replicate wells (four for 
blank control and 10X diluted AI-2 columns of DH5α grown in LB medium). 
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density of DH5α in LB medium with 0.2% glucose is only 0.7, compared to 1.4 in LB 
medium).  AI-2 had no effect on the optical density of non-disturbed wells, relative to the 
negative controls (data not shown).  AI-2 is known to stimulate biofilm formation in E. 
coli by increasing motility through MotA, a proton conductor for flagellum motion, and 
MqsR, an uncharacterized protein that stimulates th two-component motility regulatory 
system QseBC.81 
     The effect of AI-2 on biofilm formation in Bacillus cereus is shown in Figure 14.  
After 23.5 h growth, a drastic reduction (four-fold to seven-fold) in biofilm is seen in 
two-fold diluted LB medium with added AI-2, and after 45.5 h growth, a similar 
reduction is seen in two-fold diluted LB medium supplemented with 0.2% glucose (three-
fold to seven-fold).  However, the negative control c ntaining 50 µM adenine and 100 
µM DL-homocysteine reproduces this effect.  Auger et al. performed a similar 
experiment, testing various lower concentrations of AI-2 and their effect on biofilm 
formation in B. cereus grown in LB medium52.  A concentration-dependent inhibition of 
biofilm formation was observed.  They state that SAH, adenine, and homocysteine did 
not affect biofilm formation in their experiment up to concentrations of 10 µM, although 
whether they used L-homocysteine or DL-homocysteine is not stated.  L-homocysteine is 
not readily available commercially, although it can be prepared from L-homocysteine 
thiolactone by treatment with concentrated NaOH, followed by neutralization with 
KH2PO4 is available
137.  Unfortunately this procedure generates a solution of L-
homocysteine with enormous concentrations of sodium and potassium ions, and 
homocysteine tends to dimerize and precipitate out of solution in the absence of a 
reducing agent.  Thus it was not possible to prepare L-homocysteine for the purpose of 
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this work.  To further investigate whether adenine or DL-homocysteine was responsible 
for the decrease in biofilm, each was tested at different concentrations in separate biofilm 
assays (data not shown).  DL-homocysteine appeared to reduce biofilm formation at high 
concentrations, while adenine had no effect.  Interestingly, it has been shown that in B. 
cereus, the genes encoding YrhA (an O-acetylserine thiol lyase) and YrhB (a 
cystathionine γ-synthase) form an operon with luxS138, implicating the possibility of co- 
regulation. YrhA and YrhB are required for methionine to cysteine conversion through 
homocysteine as an intermediate139.  High concentrations of homocysteine, present either 
alone or in the in vitro synthesized AI-2, may be repressing luxS.  Additionally, B. cereus 
possesses an Lsr-like system52, so it is possible that glucose represses lsr transcription, 
thereby delaying importation of AI-2 until glucose is depleted.  As shown in Figure 14, 
biofilm growth in glucose-supplemented medium is very low after 23.5 hours but is 
markedly increased after 45.5 hours.  AI-2 also appe rs to induce a slight growth 
inhibitory effect in B. cereus, independent from addition of adenine and homocysteine, as 
shown in Figure 15.  
     The effect of AI-2 on biofilm formation in Listeria innocua is shown in Figure 16.  It 
was discovered late in this work that L. innocua unexpectedly always forms more biofilm 
in the fifth column of wells from the edge of the microplate in BHI medium.  Therefore 
all biofilm assay data for L. innocua was normalized column-wise against averaged 
optical densities from a control biofilm assay where L. innocua was grown in BHI and 
BHI supplemented with 0.2% glucose.  No statistically significant effect of AI-2 on 
biofilm formation in L. innocua is observed.  Although no reports exist in the litera ure 



























50 µM adenine, 100 µM DL-homocysteine
20X diluted AI-2 (~25 µM)
10X diluted AI-2 (~50 µM)
 
Figure 14: Effect of AI-2 on biofilm formation of Bacillus cereus after 23.5 h and 45.5 h of 
growth at 32°C in two-fold diluted LB medium (2X LB) and 2X LB supplemented with 0.2% 
glucose (2X LB glu).  AI-2 was sample “C” in Table 3.  Error bars represent standard deviations 



























50 µM adenine, 100 µM DL-homocysteine
20X diluted AI-2 (~25 µM)
10X diluted AI-2 (~50 µM)
 
Figure 15: Effect of AI-2 on bulk growth of Bacillus cereus after 23.5 h and 45.5 h of growth at 
32°C in two-fold diluted LB medium (2X LB) and 2X LB supplemented with 0.2% glucose (2X 
LB glu).  AI-2 was sample “C” in Table 3.  Error bars represent standard deviations about the 





































50 µM adenine, 100 µM DL-homocysteine
20X diluted AI-2 (~25 µM)
10X diluted AI-2 (~50 µM)
23.5 h 45.5 h
 
Figure 16: Effect of AI-2 on biofilm formation of Listeria innocua after 23.5 h and 45.5 h growth 
at 22°C in BHI medium and BHI medium supplemented with 0.2% glucose.  Optical densities are 
normalized as described in the text.  AI-2 was sample “C” in Table 3.  Error bars represent 
propagated standard deviations about the mean of six replicate wells. 
 
 
conducted on Listeria monocytogenes, a closely related species.  Belval et al. found that
the addition of AI-2 to 42 h old biofilms of L. monocytogenes EGD-e and a luxS mutant 
strain grown in TSB had a statistically insignificant effect, however they found that the 
addition of SRH resulted in a statistically significant increase in biofilm.8  Their luxS 
mutant strain formed denser biofilms containing more than 10 times as many attached 
cells as EGD-e, but only after 48 h growth.  Similar results were also reported by Sela et 
al.9. A luxS mutant would be expected to experience an intercellular and/or extracellular 
accumulation of SRH.  To examine whether Listeria innocua would exhibit a similar 
increase in biofilm on addition of SRH, in vitro synthesized SRH was added in the same 
manner as in vitro AI-2 (Figure 17).  The in vitro SRH induced an eleven-fold increase in 
bioluminescence in Vibrio harveyi BB170 over the control, and conversion was 
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determined by HPLC to be 82.5%.  No statistically significant effect of SRH addition was 








































20X diluted SRH (~25 µM)
10X diluted SRH (~50 µM)
 
Figure 17: Effect of SRH on biofilm formation of Listeria innocua after 22 h and 46 h growth at 
22°C in BHI medium and BHI medium supplemented with 0.2% glucose.  Optical densities are 
normalized as described in the text.  Error bars represent propagated standard deviations about the 
mean of six replicate wells. 
 
 
6.4. Effect of LuxS inhibitors on biofilm formation 
 
6.4.1. S-anhydroribosyl-L-homocysteine (SARH) 
 
     SARH, a relatively weak inhibitor of LuxS obtained from Alfaro et al., was screened 
against E. coli, B. cereus, and L. innocua at concentrations ranging from 50 µM to 2 mM.  
This compound, when added at a concentration of 2 mM to 0.34 µM of LuxS in vitro, 
reduced the concentration of homocysteine formed by 60-70% over a period of a few 
minutes121.  Figures 18, 19, 20, and 21 show the effect of SARH on biofilm formation in 
E. coli. DH5α, E. coli K-12, B. cereus, and L. innocua, respectively.  No effect on growth 
was observed at any concentration of SARH, as measur d by the optical density of 
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undisturbed cells in the 96 well plates prior to analyzing for biofilm.  As expected, SARH 
has no statistically significant effect at any conce tration on E. coli DH5α, which is a 
luxS deficient strain.  In E. coli K-12, no clear concentration-dependent effect was 
observed.  However, after growth in LB medium for 47 h, it appeared that low 
concentrations of SARH actually increased biofilm formation, followed by a reduction 
back to control levels at 0.5 mM and above.  This trend does not appear to be solely due 
to ‘edge effects’ on the 96 well plate (which could result from spatial variations in 
aeration, evaporation, and forces applied to the adhering biofilm during plate processing), 
because the column of wells containing 0.1 mM SARH was closest to the edge, with 
































Figure 18: Effect of SARH addition to biofilm formation of Escherichia coli DH5α, a luxS 
deficient strain, after 23 h and 47 h growth at 37°C in LB medium and LB supplemented with 


































Figure 19: Effect of SARH addition on biofilm formation of Escherichia coli K-12 after 23 h and 
47 h growth at 37°C in LB medium and LB supplemented with 0.2% glucose.  Error bars 
represent standard deviations about the mean of six replicate wells. 
 
 
     SARH had no effect on biofilm formation in Bacillus cereus after 26 h growth, 
however after 50.5 h growth in 2X LB, a reduction in b ofilm is seen at all concentrations 
of SARH.  The same effect is not seen in 2X LB supplemented with 0.2% glucose.  This 
appears to be due to 96 well plate ‘edge effects,' with more biofilm often being observed 
in only the sixth column of wells.  This was where th control wells (0 mM SARH) were 
located.  Furthermore, the reduction of biofilm seen in 2X LB after 50.5 h was also not 
able to be replicated in another similar experiment conducted several months later (data 
not shown)  
     As seen in Figure 21, SARH also had no statistically significant effect on biofilm 
formation in Listeria innocua. 
     Because SARH is such a weak in vitro inhibitor, its action inside a bacterial cell is 

































Figure 20: Effect of SARH addition on biofilm formation of Bacillus cereus after 26 h and 50.5 h 
growth at 32°C in two-fold diluted LB medium (2X LB) and 2X LB supplemented with 0.2% 












































Figure 21: Effect of SARH addition on biofilm formation of Listeria innocua after 26 h and 50.5 
h growth at 22°C in BHI medium and BHI supplemented with 0.2% glucose.  Optical densities 
are normalized as described in the text.  Error bars represent propagated standard deviations about 
the mean of six replicate wells. 
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Additionally, SARH is a medium sized and highly hydrophobic ribose moiety that may  
require a specific transporter protein for it to pass cross the cell membrane. 
 
 
6.4.2. Pei compounds 10 and 11 
 
     The LuxS inhibitors from Shen et al.122, herein referred to as Pei 10 and 11, are the 
most potent synthesized to date.  These compounds were screened individually against E. 
coli, B. cereus, and L. innocua at concentrations between 2 µM to 50 µM.  Figures 22, 
23, 24, 25, and 26 show the effect of Pei 10 and 11 on E. coli W3110, E. coli DH5α, E. 
coli K-12, B. cereus, and L. innocua, respectively.   
     In E. coli W3110 (Figure 22), a large increase in biofilm is evid nt from the addition 
of 50 µM of Pei 10 over the negative control when grown in LB supplemented with 0.2% 
glucose for 23 hours.  This increase may be due to increased bulk growth, with the 
undisturbed wells containing 50 µM Pei 10 having an averaged optical density of 1.2, 
whereas the wells containing 0 µM, 2 µM, and 10 µM had optical densities of 0.96, 0.78, 
and 0.76, respectively.  For all other sets of data in Figure 22, there were no significant 
variations in bulk growth (data not shown).  In LB supplemented with 0.2% glucose, both 
Pei 10 and Pei 11, at the highest tested concentration of 50 µM, appe r to slightly 
decrease biofilm formation after about 48 hours growth.  In E. coli DH5α (Figure 23), Pei 
10 and 11 have no effect on biofilm formation at any tested concentration.  This is 
expected because DH5α does not possess luxS.  For E. coli K-12 (Figure 24), a small 
edge effect is observed in many sets of data, with the columns containing the control (0 
µM), 2 µM, 5 µM, and 10 µM of either Pei 10 or 11 being located in the columns that are 
third, second, first, and fourth closest from the edge, respectively.  The inhibitors appear 

































Pei 10 Pei 11
 
Figure 22: Effect of addition of Pei compounds 10 (left) and 11 (right) on biofilm formation of 
Escherichia coli W3110 after 23 h and 50 h growth, and 23.5 h and 47 h growth, respectively, at 
37°C in LB medium and LB supplemented with 0.2% glucose.  Error bars represent standard 

































Pei 10 Pei 11
 
Figure 23: Effect of addition of Pei compounds 10 (left) and 11 (right) on biofilm formation of 
Escherichia coli DH5α after 23 h and 50 h growth, and 23.5 h and 47 h growth, respectively, at 
37°C in LB medium and LB supplemented with 0.2% glucose.  Error bars represent standard 
































Pei 10 Pei 11
 
Figure 24: Effect of addition of Pei compounds 10 (left) and 11 (right) on biofilm formation of 
Escherichia coli K-12 after 23 h and 50 h growth, and 23.5 h and 47 h growth, respectively, at 
37°C in LB medium and LB supplemented with 0.2% glucose.  Error bars represent standard 
deviations about the mean of six replicate wells. 
 
 
     In B. cereus (Figure 25), the addition of Pei 10 and 11 result in statistically 
insignificant changes in biofilm quantity.  The large variations in biofilm quantity 
observed amongst different added concentrations of Pei 11 in 2X LB medium 
supplemented with 0.2% glucose after 47 hours growth appears to be due to edge effects, 
with wells containing 0 µM, 2 µM, 10 µM, and 50 µM of Pei 11 located in columns third, 
second, first, and fourth furthest from the edge of the plate, respectively. 
     In L. innocua (Figure 26), the addition of Pei 10 and 11 also resulted in no stastically 
significant effect on biofilm formation.  There appears to be a slight reduction at all 
concentrations of both Pei 10 and 11 in BHI medium supplemented with 0.2% glucose 
after approximately 48 hours growth, but the averag optical densities are not significant 






























Pei 10 Pei 11
 
Figure 25:  Effect of addition of Pei compounds 10 (left) and 11 (right) on biofilm growth of 
Bacillus cereus after 27 h and 50 h growth, and 23 h and 47 h growth, respectively, at 32˚C in 
two-fold diluted LB medium (2X LB) and 2X LB supplemented with 0.2% glucose.  Error bars 






































Pei 10 Pei 11
 
Figure 26: Effect of addition of Pei compounds 10 (left) and 11 (right) on biofilm growth of 
Listeria innocua after 27 h and 50 h growth, and 23 h and 47 h growth, respectively, at 22˚C in 
BHI medium and BHI supplemented with 0.2% glucose.  Optical densities are normalized as 




6.5. Effect of brominated furanone on biofilm formation and growth 
 
     The brominated furanone, (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-
furanone, was obtained from Dr. Thomas Wood as a solution in 95% ethanol.  The 
furanone was screened against B. cereus, L. innocua, Pseudomonas fluorescens, and three 
strains of E. coli at concentrations ranging from 25 to 100 µg/mL.  The same amount of 
95% ethanol was added to all test wells in each experiment.   
     In E. coli W3110, the addition of brominated furanone was found to increase biofilm 
formation up to 1.5-fold in LB medium (Figure 27).  Conversely, the addition of 100 
µg/mL reduced biofilm formation by nearly 50% in LB medium supplemented with 0.2% 
glucose after 23 hours of growth.  Significant decreases in bulk growth (measured by 
taking the optical density of the wells) due to theaddition of 100 µg/mL brominated 
furanone were observed after 23 hours and 47 hours (Figure 28).  An increase in biofilm 
formation was seen despite a decrease in bulk growth in LB medium after both 23 h and 
47 h.        
     Similarly to W3110, the addition of 50-100 µg/mL of brominated furanone to E. coli 
DH5α (Figure 29) increased biofilm formation in LB medium, however the addition of 
only 25 µg/mL resulted in a small reduction in biofilm formation.  The addition of 
brominated furanone only caused a significant decrease in bulk growth (32% lower 
optical density) in LB supplemented with glucose after 47 hours. 
     The effect of addition of brominated furanone on E. coli K-12 biofilm formation is 
shown in Figure 30.  In LB supplemented with glucose, a concentration-dependent 
reduction in biofilm is observed.  The addition of 100 µg/mL of brominated furanone 
resulted in a 55% reduction in biofilm after 23 hours growth, and a 64% reduction in 
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biofilm after 47 hours growth.  These results are very similar to those previously reported 
for E. coli JM109, which exhibited a 51% decrease in biofilm formation on the addition 
of 100 µg/mL furanone, when grown in LB supplemented with 0.2% glucose76.  Because 
glucose supplementation stimulates AI-2 synthesis in E. coli by indirectly upregulating 
luxS, the decreases in biofilm formation seen in E. coli W3110 and K-12 (DH5α is a luxS 
negative strain) when grown in LB medium supplemented with 0.2% glucose indicate 
that the brominated furanone may be attenuating AI-2 quorum sensing.  The mechanism 
by which the brominated furanone influences DH5α is not known.  
      The addition of brominated furanone to Listeria innocua strongly quenches biofilm 
formation, with minimum biofilm evident with the addition of 50 µg/mL (Figure 31).  At 
a concentration of 100 µg/mL furanone, biofilm formation in BHI medium increases over 



























Figure 27: Effect of addition of brominated furanone on biofilm growth of Escherichia coli 
W3110 after 23 h and 47 h growth at 37˚C in LB medium and LB supplemented with 0.2% 



































Figure 28: Effect of addition of brominated furanone on bulk growth of Escherichia coli W3110 
after 23 h and 47 h growth at 37˚C in LB medium and LB supplemented with 0.2% glucose.  
These readings are optical densities of non-disturbed wells.  Error bars represent standard 





























Figure 29: Effect of addition of brominated furanone on biofilm growth of Escherichia coli 
DH5α after 23 h and 47 h growth at 37˚C in LB medium and LB supplemented with 0.2% 

































Figure 30: Effect of addition of brominated furanone on biofilm growth of Escherichia coli K-12 
after 23 h and 47 h growth at 37˚C in LB medium and LB supplemented with 0.2% glucose.  
Error bars represent standard deviations about the mean of five or six replicate wells. 
 
In BHI medium supplemented with 0.2% glucose, the addition of 100 µg/mL furanone 
results in less biofilm formation than the addition f 25 µg/mL furanone, with 50 µg/mL 
remaining the optimal tested concentration.  It is immediately apparent from Figure 32 
that the addition of furanone also strongly quenches bulk growth in Listeria innocua.  To 
determine whether biofilm growth was reduced relative to bulk growth, the ratio of 
optical densities in Figure 31 to Figure 32 is plotted in Figure 33.  At a concentration of 
100 µg/mL furanone, although less biofilm is formed than in the control, more biofilm is 
formed relative to the bulk growth in medium.  At a concentration of 25 µg/mL furanone, 
biofilm is reduced relative to bulk growth over the control.  Thus the brominated 
furanone preferentially targets biofilm formation of Listeria innocua at lower 































Figure 31: Effect of addition of brominated furanone on biofilm growth of Listeria innocua after 
23 h and 48 h growth at 22˚C in BHI medium and BHI supplemented with 0.2% glucose.  Error 
































Figure 32: Effect of addition of brominated furanone on bulk growth of Listeria innocua after 23 
h and 48 h growth at 22˚C in BHI medium and BHI supplemented with 0.2% glucose.  These 
readings are optical densities of non-disturbed wells.  Error bars represent standard deviations 































Figure 33:  Effect of brominated furanone on biofilm growth in Listeria innocua normalized to 
the non-disturbed optical densities.  The ratio of destained crystal violet optical densities at 595 
nm in Figure 31 were divided by the optical densitie  in Figure 32.  Error bars represent 
propagated standard deviations about the mean of six replicate wells. 
 
L. innocua, the mechanism by which the furanone quenches biofilm formation and 
growth is not understood.   
     In Bacillus cereus, high concentrations of brominated furanone increase biofilm 
formation in two-fold diluted LB medium and greatly decrease biofilm formation in two-
fold diluted LB medium supplemented with 0.2% glucose (Figure 34).  Minimum biofilm 
formation results from the addition of 25 µg/mL furanone after 23 h growth, and from the 
addition of 50 µg/mL furanone after 48 hours growth.  Bulk growth in media is also 
quenched by the addition of furanone (Figure 35), similarly to L. innocua.  The addition 
of 25 µg/mL furanone almost completely eliminates growth for at least 23 hours in 
medium with or without supplemental glucose.  After 48 hours, cell density recovers in 
glucose-supplemented medium with 25 µg/mL furanone.  However, at 50 µg/mL 
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furanone, growth remains minimal after 48 hours.  The ratio of optical density in Figure 
34 to Figure 35 is plotted in Figure 36.  The brominated furanone only preferentially 
targets biofilm formation of Bacillus cereus over bulk growth at a concentration of 25 
µg/mL in a glucose-supplemented medium at the 48 hour time point.  Ren et al. observed 
that 20 µg/mL furanone significantly extended the lag phase of growth in Bacillus 
subtilis, and 40 µg/mL completely inhibited growth in shake flasks but did not 
completely inhibit biofilm formation131.  The results presented here on B. cereus are in 
close agreement with these observations.  Ren et al. also observed that 40 µg/mL 
furanone decreased the percentage of live cells (determined by live/dead staining) in B. 
subtilis biofilms compared to the control.  Because crystal vio et interacts with many 
negatively-charged cell components, dead cells in the biofilm may contribute to the 
destained optical densities seen in Figure 34.  These r sults extend the list of Gram-
positive species known to exhibit inhibited growth and biofilm formation due to the 
addition of brominated furanone.  They also provide evidence that under certain 
conditions, biofilm growth is preferentially inhibited relative to bulk growth.  It is not 
clear how these results could be related to AI-2 quorum sensing in either B. cereus or L. 
innocua.  The furanone has been shown to induce several heat s ock and ribose transport 
and metabolism genes in B. subtilis, alluding no connection to quorum sensing140. 
     Because the brominated furanone also has been shown to interfere with AHL quorum 
sensing, it was also screened against Pseudomonas fluorescens, a species lacking LuxS.  
Although P. fluorescens cannot produce AI-2, it is possible that it can detect or uptake it 
from the environment, as is the case with P. aeruginosa141.  P. fluorescens produces 
































Figure 34: Effect of addition of brominated furanone on biofilm growth of Bacillus cereus after 
23 h and 48 h growth at 22˚C in two-fold diluted LB(2X LB) medium and 2X LB supplemented 
































Figure 35: Effect of addition of brominated furanone on bulk growth of Bacillus cereus after  23 
h and 48 h growth at 32˚C in two-fold diluted LB (2X LB) medium and 2X LB supplemented 
with 0.2% glucose.  These readings are optical densiti s of non-disturbed wells.  Error bars 






























Figure 36:  Effect of brominated furanone on biofilm growth in Bacillus cereus normalized to the 
non-disturbed optical densities.  The ratio of destained crystal violet optical densities at 595 nm in 
Figure 34 were divided by the optical densities in F gure 35.  Error bars represent propagated 
standard deviations about the mean of six replicate wells. 
 
tetradecanoyl)homoserine lactone, N-tetradecanoylhomo-serine lactone, N-(3-
hydroxydecanoyl)homoserine lactone, and N-(3-oxodecanoyl)-homoserine lactone37.  
The brominated furanone had virtually no effect on biofilm formation in nutrient broth or 
LB supplemented with 1.0% sodium citrate (citrate supplementation promotes biofilm 
formation in P. fluorescens141), with only a slight decrease observed after 48 hours in 
nutrient broth (Figure 37).  However, a concentration-dependent decrease in bulk growth 
(39% reduction in optical density with the addition f 100 µg/mL furanone over the 
control) is observed in LB supplemented with 1.0% sodium citrate after 23 hours (Figure 
38).  No reports in the literature have observed a brominated furanone dependent growth 
limitation in any Pseudomonas species.  One possibility is that a larger iron limitation 
exists in LB medium than in nutrient broth, which contains beef extract.  Although iron 
limitation does not affect the growth rate, it has been shown to decrease the stationary 
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phase cell density in P. aeruginosa143.  Bacteria produce siderophores to chelate iron in 
iron-limited environments.  If the addition of brominated furanone represses siderophore 
synthesis, as it does in P. putida in a concentration-dependent manner129, it is possible 
that P. fluorescens has a reduced ability to uptake iron and therefore reaches a lower 
stationary phase cell density.  It is not clear why reduced cell density due to brominated 
furanone is not observed in LB medium supplemented with 1.0% sodium citrate after 48 
hours.  
     E. coli also synthesizes numerous siderophores, with one of the best studied being 
enterochelin (enterobactin).  Enterochelin-mediated iron transport is essential for growth 
under iron-deficient conditions144.  However, genes encoding enzymes involved in 
































Figure 37: Effect of addition of brominated furanone on biofilm growth of Pseudomonas 
fluorescens after 23 h and 48 h growth at 22˚C in nutrient broth and LB supplemented with 1.0% 































Figure 38: Effect of addition of brominated furanone on bulk growth of Pseudomonas 
fluorescens after 23 h and 48 h growth at 22˚C in nutrient broth and LB supplemented with 1.0% 
sodium citrate.  Error bars represent standard deviations about the mean of six replicate wells. 
 
brominated furanone, and are repressed by growth in glucose-supplemented medium, 
which increases AI-2 synthesis76.  Thus the proposed mechanism by which growth is 
inhibited by brominated furanone in P. fluorescens is likely not the case for E. coli.   
 
6.6. Effect of LuxS inhibitors on AI-2 production in Listeria innocua 
 
     As shown in Figure 39, Pei 10 and 11 have no effect on growth rate in L. innocua 
cultures grown at 22˚C on an air shaker at 250 rpm.  The growth constants calculated for 
the control (no added inhibitor), Pei 10, and Pei 11 are 0.57 h-1, 0.58 h-1, and 0.58 h-1, 
respectively.  To determine whether Pei 10 and 11 actually reduce the level of 
autoinducer-2 activity in the supernatant, cell-free supernatants were collected at various 
time points directly from the samples removed to take the optical density measurements 
in Figure 39.  It was found that components in non-diluted BHI medium repressed 
bioluminescence in Vibrio harveyi, whereas ten-fold diluted BHI medium induced 
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bioluminescence after 4 hours, thereby mimicking the autoinducer-2 response.  Catabolite 
repression of luciferase biosynthesis in Vibrio harveyi due to high levels of glucose is 
well known145.  It is possible that other nutrients can also act as catabolite repressors.  
Turovskiy and Chikindas report that a modified BHI medium completely quenches the 
bioluminescent response of V. harveyi, as does the addition of 0.5 to 2.0 g/L of glucose t  
samples145.  Furthermore, the presence of 0.03 to 0.13 g/L of glucose was shown to 
nonlinearly induce bioluminescence.  Therefore the collected cell-free supernatants from 
L. innocua were depleted by inoculating with V. harveyi MM30, a luxS deletion mutant 
of V. harveyi BB120, following a procedure similar to that employed by Turovskiy and 
Chikindas146.  The depleted cell-free supernatants were then analyzed for their ability to 
induce bioluminescence in V. harveyi BB170.  Because the effects of Pei 10 and 11 on 
the reporter strain are unknown, negative control samples were incorporated that 
contained V. harveyi MM30 depleted fresh medium with 50 µM of each inhibitor or only 
PBS.  The bioluminescence measured from each L. innocua cell-free supernatant was 
then divided by the bioluminescence measured from the appropriate control.  The 
normalized bioluminescence measurements for each collected time point after 4 hours 
incubation are shown in Figure 40.  Four hours was selected because it was the final 
measurement time before the bioluminescence of control samples began increasing.  It is 
likely that the depletion by V. harveyi MM30 was not complete, and very small levels of 
glucose or other media components were still interfering with the activity assay.  
Surprisingly, normalized bioluminescent measurements from samples containing either 
Pei 10 or 11 inhibitors were lower than the negative control containing only PBS at L. 
innocua growth times between 2.5 to 5.25 hours.  This is indicative of lower levels of 
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extracellular AI-2, which would be expected if the inhibitors were being internalized by 
the cells and competitively inhibiting LuxS.  At 8.25 hours and 24 hours, samples 
containing Pei 10 and 11 no longer have reduced bioluminescence relative to the control.  
The effect of the inhibitors on AI-2 production therefore appears to be transient on a 
time-scale well below that required for significant i itiation of biofilm formation.  
Simulations on competitive and uncompetitive inhibitors in a model open system (having 
constant input of substrates and removal of products) have shown that competitive 
inhibitors result in very mild and transient responses in situations where the accumulating 
intermediate cannot be degraded in a rapid alternative pathway147.  SRH can only be 
degraded by LuxS, so its accumulation would be self-limiting as mass action overcomes 
inhibition.  Another factor that would reduce the effectiveness of all of the studied LuxS 
inhibitors is their extreme hydrophilicity.  An ability to bind to specific transporters in 
order to pass through the inner cell membrane would likely be required.  Pei 10 and 11 
both closely resemble methionine on one end, leaving open the possibility that 
methionine transporters can import these molecules.  E. coli possesses both a high-
affinity and a low-affinity methionine transporter and can import L-methionine, D-
methionine, N-acetylmethionine, and methionine sulfoxide.148,149  The metNPQ operon in 
B. subtilis encodes an ABC transporter that can import D-methionine, L-methionine, and 
methionine sulfoxide, with an unidentified transporter also able to uptake L-methionine 
and methionine sulfoxide.150  The KEGG Pathway Database (http://www.genome.jp/kegg 
/pathway.html) lists orthologues of metNPQ in B. cereus and L. innocua.  More studies 
need to be conducted to determine if Pei 10 and 11 can pass through the inner cell 






































Figure 39:  Growth of Listeria innocua in the presence of 50 µM Pei 10 (squares), 50 µM Pei 11 
(triangles), and a negative control containing the same quantity of PBS (diamonds) in BHI 
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Figure 40:  Autoinducer-2 activity assay of Listeria innocua cell-free supernatants taken at 
different growth times in the presence of 50 µM of Pei10 or Pei 11 dissolved in PBS, or a control 
containing the same amount of PBS.  Relative light units (RLU) of each sample were normalized 
to RLUs from a control containing depleted fresh medium with the same concentration of 
inhibitors dissolved in PBS, or only PBS for the negative control.   
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Chapter 7:  Conclusions 
 
     This work investigated the effect of in vitro synthesized AI-2, three LuxS inhibitors 
and a brominated furanone inhibitor on biofilm formation in Escherichia coli, Bacillus 
cereus, and Listeria innocua.  Additionally, autoinducer-2 activity was characterized in L. 
innocua cell-free supernatants grown in the presence of two potent LuxS inhibitors.   
     In vitro synthesized AI-2 results in increased biofilm formation in E. coli.  A 
depletable level of glucose supplementation accentuates the increase in biofilm due to AI-
2 in E. coli W3110, likely through stimulation of luxS expression via cAMP-CRP.  In B. 
cereus, addition of in vitro synthesized AI-2 results in large reductions of biofilm that 
appears to be due to the addition of large concentrations of homocysteine present as a 
reaction product.  The addition of glucose greatly decreases biofilm formation in B. 
cereus, possibly due to repression of lsr transcription in a manner similar to E. coli.  The 
addition of AI-2 to L. innocua had no effect on biofilm formation, nor did the addition of 
in vitro synthesized SRH. 
     The LuxS inhibitor SARH had no clear effect on any of the tested bacteria, which was 
an expected result due to its lack of potency and very hydrophilic nature.  Pei compounds 
10 and 11 appear to have decreased biofilm formation in E. coli W3110 by 38% and 
34%, respectively, in LB medium supplemented with 0.2% glucose after 50 hours 
growth.  Glucose would be expected to magnify the eff ct of LuxS inhibitors by initially 
stimulating luxS expression while inhibiting AI-2 uptake.  Pei 10 and 11 had no effect on 
biofilm formation in B. cereus and L. innocua.   
     The brominated furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone 
was found to increase biofilm formation in E. coli W3110 in LB medium, while 100 
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µg/mL furanone sharply decreased bulk growth in LB medium with and without added 
glucose.  The furanone also generally increased biofilm formation in E. coli DH5α in LB 
medium, without an effect on bulk growth.  A concentration-dependent reduction in 
biofilm formation was observed in E. coli K-12, but only in glucose-supplemented 
medium.  In L. innocua and B. cereus, which are both Gram-positive, bulk growth and 
biofilm formation were strongly quenched.  Normalized to bulk growth, biofilm 
development in L. innocua is preferentially inhibited by furanone in glucose-
supplemented medium.  In B. cereus, bulk growth is preferentially quenched relative to 
biofilm development in a concentration-dependent manner.  The brominated furanone 
appears to reduce bulk growth of Pseudomonas fluorescens in LB medium supplemented 
with 1.0% sodium citrate at 23 hours, possibly through repression of siderophore 
synthesis.   
     L. innocua was grown in the presence of LuxS inhibitors Pei 10 and 11, and nutrient-
depleted cell-free supernatants were analyzed for AI-2 activity based on their ability to 
induce bioluminescence in Vibrio harveyi BB170.  Transient reductions in AI-2 
production of 20 to 40 percent were observed during the exponential growth phase.  It is 
postulated that the level of inhibition may be too l w and too transient to induce changes 
in biofilm phenotype under most circumstances.  Pei10 and 11 may be transported into 
the cell via methionine transporters.   
     A plethora of future work can be suggested based on the results of this study.  
Analysis of AI-2 activity in cell-free supernatants from B. cereus and E. coli grown in the 
presence of Pei 10 and 11 LuxS inhibitors would provide valuable additional information 
(this study was limited by the quantity of inhibitors available).  Microscopy of biofilms 
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grown in the presence of inhibitors and AI-2 would allow biofilm morphology to be 
determined.  The transport of inhibitors into bacterial cells needs to be better understood, 
and attempts should be made to deliver inhibitors into the cell (eg. through the use of 
vesicles).  The development of in vivo models of enzyme inhibition coupled with 
metabolic networks should be pursued for making predictions on the effects of quorum 
sensing inhibitors prior to exhaustive screening studies.  Finally, the precise mechanism 
of action of brominated furanones, particularly against growth and biofilm formation in 
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